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P2X receptors are a family of genes encoding seven homologous subunits 
which form ion channels that are permeable to Na+, K+, and Ca2+ ions upon 
activation by ATP.  Expressed in excitable and non-excitable cells, the P2X2 
receptor has been shown to have broad physiological importance in 
neuromuscular junction development, gustatory sensation, and the regulation of 
urinary bladder function.  The ATP-evoked responses of P2X2 receptors are 
allosterically modulated by divalent zinc and protons.  We have used site-
directed mutagenesis and two-electrode voltage clamp electrophysiology to test 
whether any of the 34 extracellular aspartate and glutamate residues of the ATP-
gated rat P2X2 receptor are important for general channel function, pH 
potentiation, or zinc modulation.  All of the extracellular acidic residues tested 
produced functional channels with only small changes in ATP potency or 
maximal response.  Seven candidates (D82, E85, E91, E115, D136, D209, and 
D281) showed significantly reduced zinc potentiation, and one candidate (E84) 
showed significantly reduced zinc inhibition.  Further tests with cysteine versions 
of the eight identified candidates and thiol-reactive MTSET suggested that only 
D136 remains a good candidate to directly bind zinc at the potentiation site, and 
there were no good candidates for zinc inhibition.  When the 34 alanine 
substituted mutants were screened for ability to potentiate to acidic pH, E63 
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showed significantly reduced pH potentiation as compared with wild type P2X2.  
Molecular level understanding of the structure-function relationship of allosteric 
sites of these receptors might allow for development of selective drugs that target 
allosteric sites, which could lead to safer therapies with fewer side effects than 








1.0 Receptor-mediated excitation and inhibition in neurons 
There are two broad mechanisms of receptor-mediated excitation and 
inhibition in central and peripheral neurons.  One mechanism involves G-protein 
coupled receptors (GPCRs).  GPCRs are the largest family of membrane-bound 
receptors, and there are five main human GPCR families--Rhodopsin, Secretin, 
Adhesion, Glutamate and Frizzled/Taste2 (Lagerstrom & Schioth 2008).  All 
GPCRs possess seven hydrophobic membrane-spanning segments (Larhammar 
et al. 1993, Kobilka et al. 1988). 
In general, GPCRs mediate slowly developing (onset is longer than 50 
ms) but long lasting (many seconds to minutes) changes in the excitability of 
neurons.  The slow time course of responses mediated at GPCRs is based on a 
multistep process that includes agonist binding and subsequent activation of one 
or more intracellular signaling pathways and possibly some ion channels.  Ion 
channel phosphorylation and resulting changes in channel open probability are 




Ligand-gated ion channels (LGICs), like GPCRs, also mediate changes in 
neuronal excitability.  LGICs are composed of several homologous subunits 
arranged in a ring to form a central ion-conducting pore, having the ligand 
binding site and ion channel as part of the same multimeric complex.  This broad 
class of receptors mediates fast synaptic responses.  As these receptor/ ion 
channels do not require generation of intracellular 2nd messenger molecules to 
convey the primary signal, response latencies (<1 ms) and durations (<100 ms) 
are very short. 
Ion channels are widespread in virtually all organisms where they mediate 
receptor signaling, membrane potential maintenance, accumulation and 
transduction of electrochemical energy, and generation and spreading of action 
potential.  Since chemically activated channels are crucial for synaptic 
transmission in the nervous system, comprehension of the mechanisms involved 
in the operation of LGICs at the cellular and molecular level is essential for 
gaining insight into the pathogenesis of many psychiatric and neurological 
disorders and for efficient development of novel specifically targeted drugs 
(Krusek et al. 2004). 
Ion channels can exist in various states e.g. resting, activated, 
desensitized, and inactivated.  Binding of the endogenous ligand 
(neurotransmitter) to an LGIC causes activation of the channel from the resting 
(closed) conformational state, and typically stabilizes the channel in an activated 
(open) state.  The binding site for the natural ligand, that activates the receptor, is 
known as the orthosteric binding site.  In addition, the binding of ligands at other 
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sites on the receptor surface can modify the functioning of the receptor.  This 
concept of modulation of LGIC activity by the binding of a second ligand, or 
allosteric modulator, is termed, allosteric modulation (Karlin 1967).  The binding 
site for an allosteric modulator is an allosteric binding site and each receptor may 
have several allosteric binding sites which are selective for different ligands.  
Activation of these allosteric binding sites results in changes in the affinity for the 
agonist or efficacy by which the channel is opened (Krusek et al. 2004). 
Positive allosteric effectors enhance agonist-induced responses whereas 
negative allosteric effectors reduce receptor function.  Allosteric modulators can 
change the current amplitude (potentiation or inhibition) and/ or time course 
(desensitization rate) of agonist-evoked responses.  In addition to modulating 
LGICs, allosteric modulation can affect a wide range of cellular proteins including 
enzymes and metabotropic membrane receptors (Soudijn et al. 2002, 
Christopoulos 2002). 
In mammals, one way to classify LGICs is according to the number of 
transmembrane (TM) segments present in the subunits that form the channels.  
By this criterion there are three families, with two, three and four transmembrane 
segments respectively.  The simplest LGIC family includes the adenosine 5’-
triphosphate (ATP)-activated P2X receptors and acid-sensing ion channels 
(ASICs); each subunit of these cationic channels contains two TM segments 
separated by a large extracellular loop (Khakh & North 2006).  These are made 
up of three homologous subunits.  It remains unclear whether these two classes 
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of channels (ASICS and P2X) share a common evolutionary origin, as there is no 
sequence similarity. 
A second family is the ionotropic glutamate-activated cationic receptors, 
which include N-methyl-D-aspartate (NMDA), α-amino-3-hydroxy-5-methyl-4-
isoxazolepropionic-acid (AMPA) and kainate receptors.  Members of this family 
have subunits with three TM segments with a ‘P-loop’ separating the first and 
second TM segments.  These are made up of four homologous subunits. These 
channels clearly are distantly related to the voltage gated sodium, potassium and 
calcium channel family. 
The third and largest LGIC family is the ‘Cys-loop receptor superfamily’, so 
called because of a conserved cysteine loop in their extracellular domain.  This 
family includes both anionic glycine (GlyR) and γ-aminobutyric acid type A and 
type C (GABAaR, GABAcR) channels, and cationic nicotinic acetylcholine 
receptors (nAChRs), serotonin receptors (5-HT3), histamine receptors and 
recently identified zinc-activated channels (Davies et al. 2003).  The subunits of 
Cys-loop receptors have four TM segments, with a large intracellular domain 
between TM segments 3 and 4.  Functional receptors of this family are made up 
of five homologous subunits. 
In all three families of channels the subunit composition can be 
homomeric or heteromeric and, as a result they display a great diversity of 
physiological and pharmacological properties (Hogg et al. 2005). 
AMPA and NMDA receptors mediate most of the fast excitatory synaptic 
transmission in the brain and spinal cord, although their excessive activation 
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causes glutamate-induced neurodegeneration e.g. Alzheimer dementia 
(Henneberry 1992).  They are permeable to monovalent cations.  All NMDA 
receptors and some AMPA receptors are also highly permeable to calcium.  
Glutamate is the sole neurotransmitter activating AMPA receptors, but NMDA 
receptors are gated by two different agonists, glutamate and glycine.  Small ions 
such as protons, Zn2+, Ca2+, and Cu2+ act through allosteric sites to affect the 
efficacy of channel opening, and thereby affect excitatory synaptic transmission 
mediated by AMPA and NMDA receptors and other LGICs. 
In contrast, the GABAA receptor represents the main fast inhibitory LGIC 
in the brain.  This chloride ion conducting channel is activated by γ-amino butyric 
acid and allosterically modulated by benzodiazepines and other compounds such 
as the antihelmintic avermectin drugs (Krusek et al. 2004). 
 
1.1 Adenosine 5’-Triphosphate (ATP) 
 
Adenosine 5’-triphosphate (ATP) is widely recognized for its fundamental 
metabolic role as the energy currency of the cell.  Expenditure of ATP provides 
the input of free energy necessary for cellular work, biosynthesis, catabolism, 
and active transport.  In addition to this indispensible role in all living things, ATP 
has further importance in multicellular animals: ATP acts as an intercellular 
signaling molecule which regulates various processes such as the cell cycle, 
programmed cell death, membrane and cytoskeletal remodeling, and modulation 
of excitability in neurons. 
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ATP and other nucleotides can be released from cells through regulated 
pathways, or following the loss of plasma membrane integrity (Brake & Julius 
1996).  Extracellular ATP activates cell-surface metabotropic and ionotropic 
nucleotide (P2) receptors in vascular, neural, connective, and immune tissues.  
P2 receptors mediate a wealth of physiological processes, including nitric oxide-
dependent vasodilation of vascular smooth muscle (Ralevic & Burnstock 1991) 
and fast excitatory neurotransmission in sensory afferents (Lustig et al. 1993).  
Thus, ATP has multiple critical functions as the source of chemical energy for 
intracellular housekeeping, while also serving as an autocrine or paracrine signal 
of homeostasis, pathogenesis, and injury at the cellular and tissue level 
(Gerasimovskaya et al. 2002). 
ATP is known to be a co-transmitter at neuroneuronal and neuroeffector 
synapses.  ATP may act at pre- and postsynaptic sites and therefore, it may 
participate in the phenomena of long-term potentiation and long-term depression 
of excitatory synaptic transmission.  The regulated release of ATP into the 
extracellular space, e.g., by exocytosis, membrane transporters, and connexin 
hemichannels, is a widespread physiological process (Franke et al. 2006). 
Criteria for a neurotransmitter include regulated release, the presence of 
specific receptors, and a mechanism for clearance (Finger et al. 2005).  ATP is 
released by vesicular, anion channel, and hemichannel mechanisms, activates 
P2 receptors, and is cleared from the extracellular space by ectonucleotidases 




Metabotropic pyrimidine and purine nucleotide receptors (P2YRs) belong 
to the GPCR superfamily.  They are distinguishable from adenosine receptors 
(P1) as they bind adenine and/or uracil nucleotide triphosphates or diphosphates 
depending on the subtype.  Over the past decade, P2Y receptors have been 
cloned from a variety of tissues and species, and as many as eight functional 
subtypes have been characterized (Schoneberg et al. 2007).  However, the focus 
of this thesis is the ionotropic P2X2 receptor. 
 
1.2 Ionotropic P2X Purinoceptors 
ATP-gated ion channels were first cloned from smooth muscle of rat vas 
deferens (rP2X1) and rat Phaeochromocytoma (PC12) cells (rP2X2).  So far, 
seven different mammalian genes have been found to encode P2X receptor 
subunits (P2X1 – P2X7), ranging from 379 (P2X6) to 595 (P2X7) amino acid 
residues in length.  The products of this gene family are 40 to 50% identical in 
amino acid sequence (Girdler & Khakh 2004).  There is no report of homology of 
sequence between P2X receptors and other proteins, although a similarity has 
been suggested to class II aminoacyl-tRNA synthetases (North 2002). 
No P2X-related gene has been identified in the whole genomes of the 
model invertebrates Drosophila and C. elegans.  However, there are now several 
reports of homologous sequences from invertebrate species: including the 
parasitic flatworm Schistosoma mansoni (Raouf et al. 2005, Agboh et al. 2004), 
the social amoeba Dictyostelium discoideum (Fountain et al. 2007), and 
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Ostreococcus tauri, a primitive green algae of Prasinophyceae, that is close to 
the evolutionary origins of photosynthetic plants (Fountain et al. 2008). 
In vertebrates, P2X receptors are expressed in the central and peripheral 
nervous systems, as well as in non-neuronal cell types in vascular, connective, 
and immune tissues (North 2002).  These receptors have been characterized on 
smooth muscle cells and autonomic and sensory neurons, where they mediate 
membrane depolarization and in some cases, Ca2+ entry. P2XRs allow released 
extracellular ATP to act as a signaling molecule in autocrine and paracrine 
signaling processes (Stojilkovic & Koshimizu 2001, Gerasimovskaya et al. 2002, 
Placido et al. 2006) and neurotransmission (Burnstock 2007a). 
P2X receptors functionally resemble glutamate-gated, acetylcholine-gated 
and serotonin-gated channels with respect to cationic selectivity and fast 
activating kinetics of channel gating, but as noted above they belong to 
completely different gene familes and make proteins with very different 
structures.  Thus, the P2X receptor provides a striking example of convergent 
evolution, whereby proteins have been fashioned with similar functional 
properties from subunits having very different structural characteristics (Brake et 
al. 1994).  Ionotropic P2X receptors are also structurally distinct from the G-
protein coupled metabotropic P2Y ATP receptors and other LGICs. 
 P2X receptors show considerable differences in their sensitivity to 
naturally occurring agonists, P2 receptor antagonists, allosteric modulators and 
furthermore show differences in kinetics of receptor activation and inactivation.  
Such diversity in the operational profiles of ATP-gated ion channels may be 
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attributable to the subunit composition of native P2XRs because other classes of 
ionotropic receptors show differing phenotypes that depend on subunit 
composition (King et al. 2000). 
 
1.3 P2XR distribution, topology, and expression 
P2X receptors are abundantly distributed, and functional responses are 
seen in neurons, glia, epithelia, endothelia, bone, muscle, and hemopoietic 
tissues (North 2002). 
Investigation of transmembrane topology was initially done by Torres and 
others, where they expressed P2X2 subunits in tandem revealing that the N and 
C-termini are on the same side of the plasma membrane.  Immunofluorescence 
further resolved this to both termini being intracellular (Fig. 1.1).  Studies with N-
glycosylation reporters showed that the central loop between the two 
transmembrane domains is extracellular (Torres et al. 1998).  The N-terminus is 
quite short and has a strictly conserved protein kinase C (PKC) phosphorylation 
site at Threonine-18 (P2X2 numbering), which is important for desensitization.  
The C-terminus is variable in length among P2XRs, but is uniformly larger than 
the N-terminus (Girdler & Khakh 2004).  While not all P2X receptors have as 
many as 400 amino acids, the P2X2 receptor is phosphorylated by protein kinase 
A at Serine-431 on the intracellular C-terminal domain which regulates the 
amplitude but not the kinetics of ATP-evoked responses in HEK293 cells (Chow 
& Wang 1998). 
9 
 
Some cells express more than one type of P2X receptor subunit.  Six of 
the seven cloned P2X receptors are believed to form functional homotrimeric 
assemblies (Barrera et al. 2005).  However, the P2X6 receptor does not form 
stable homotrimers, and when expressed alone is retained in the endoplasmic 
reticulum in monomeric form (Ormond et al. 2006). 
P2XRs can also coassemble with other P2X subunits to form heteromeric 
P2X assemblies of three protein subunits per ATP-gated ion channel.  Examples 
of functional heteromeric P2X receptors include P2X2/3, P2X2/6, P2X4/6, and P2X1/5 
(King et al. 2000).  The rP2X2/6 receptor is a functionally modified P2X2-like 
receptor with a distinct pattern of pH modulation of ATP activation.  Although 
homomeric P2X6 receptors function poorly, the P2X6 subunit can contribute to 
functional heteromeric P2X channels and may influence the phenotype of native 
P2X receptors in those cells in which it is expressed (King et al. 2000).  P2X5 can 
coassemble with all other P2XRs except P2X7.  The prevailing view until recently 
was that P2X7 subunits only form homomeric channels.  There is now a report of 
biochemical and electrophysiological evidence for the existence of P2X4/7 
heteromeric receptors (Dubyak 2007). 
Channels composed of splice variants of a P2X subunit (e.g. rP2X2a and 
rP2X2b) can also generate different phenotypic forms of P2X receptors (King et 
al. 2000).  ATP-activated currents mediated by heterologously expressed P2X2a 
and P2X2b receptors showed significant differences in desensitization time 
constants and steady-state currents in the continuous presence of ATP (Brandle 
et al. 1997).  These results imply functional differences between cells 
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differentially expressing these P2X2 isoforms.  Further differences in function may 
possibly be generated by heteromeric combinations of isoforms of a given 
subunit type. 
 
1.4 In vivo studies of P2X receptors using genetically altered mice 
Genetically altered mice are an extremely powerful tool for understanding 
the in vivo function of proteins and provide useful models of human genetic 
disorders.   Many different manipulations are possible, including gene knock out, 
knock in replacement and transgenic insertion at a different chromosomal 
location.  Many of the uses of genetically altered mice in physiology have been 
recently reviewed.  (Picciotto & Wickman 1998). 
 
Currently, there around 50 reports of in vivo studies that used genetically 
modified mouse models to study the biological function of members of the P2X 
receptor family.  None of the reports describe embryonic lethality owing to P2XR 
knockout, so the receptors do not appear to be critical for regulation of prenatal 
developmental events.  The majority of studies have been done on P2X7 
knockout mice, and there are no reports of transgenic or knockout rodent models 
of P2X5 or P2X6 receptor function.  Further, knock in studies are needed to test 
whether P2XR mutations identified to be candidates for functional importance by 
chimerization, mutagenesis, and biochemical studies in heterologous expression 
and in vitro systems are in fact relevant in the whole intact organism. 
Nonetheless, the available studies have provided a wealth of insight into 
the broad physiological relevance of P2XRs, while also identifying molecular 
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targets for design of therapeutics.  The following section is intended to illustrate, 
using representative examples from the literature, some of the ways in which 
transgenic or knockout mice have been used to analyze the physiological 
relevance of the P2X receptor family of ATP-gated cation channels in a variety of 
tissues and organ systems. 
 
P2X1 
Knock-out studies using mice have shown that the P2X1 receptor has a 
direct physiological role in normal male reproductive function (Mulryan et al. 
2000), cytokine release from peritoneal macrophages (Sim et al. 2007), platelet 
aggregation (Hechler et al. 2003), and autoregulation of preglomerular 
vasoconstriction (Inscho et al. 2004). 
 
P2X2 
No deficits in a wide variety of central nervous system behavioral tests 
were observed in P2X2-/- mice (Cockayne et al. 2005).  However, mice lacking 
the P2X2 nucleotide receptor showed abnormalities in neuromuscular junction 
structure and skeletal muscle function (Ryten et al. 2007), urinary voiding (Wang 
et al. 2005), and peristalsis of the small intestine (Ren et al. 2003).  Additional 
studies have demonstrated that ATP-evoked currents measured in rat otic 
neurons are due to the expression of P2X2 receptors (Ma et al. 2004), and that 
P2X2 plays a pivotal role in carotid body function and in mediating ventilatory 




P2X1 / P2X2 
P2X1 knock out studies have shown that heteromeric channels 
incorporating the properties of P2X1 and P2X2 receptors are present in 
sympathetic postganglionic neurons from the superior cervical ganglia.  Thus, the 
P2X1 receptor can contribute to the properties of heteromeric P2X receptors, and 
it is likely that regulation of the properties of P2X receptors by this subunit occurs 
in other P2X1 expressing neurons (Calvert & Evans 2004). 
 
P2X3 
Mice lacking the P2X3 ATP receptor exhibit attenuated responses to 
bladder distension (Vlaskovska et al. 2001), impaired peristalsis in the intestine 
(Bian et al. 2003), persistent nociceptive signaling in models of acute and chronic 
pain (Jarvis 2003), altered coding of peripheral warm stimuli (Shimizu et al. 
2005), and abnormalities in long-term depression of hippocampal neurons (Wang 
et al. 2006). 
 
P2X2 / P2X3 
P2X receptors on sensory neurons involve almost exclusively P2X2 and 
P2X3 subunits.  P2X2-/-, P2X3-/-, and P2X2/P2X3(Dbl-/-) mice had reduced 
urinary bladder reflexes and decreased pelvic afferent nerve activity in response 
to bladder distension, revealing an important contribution of heteromeric P2X2/3 
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receptors to nociceptive responses and mechanosensory transduction within the 
urinary bladder (Cockayne et al. 2005). 
Mice lacking both P2X2 and P2X3 receptors have enlarged spleens and 
this is correlated with an increase in the number of immune cells, perhaps as a 
consequence of a compromised immune system and chronic infection (Coutinho-
Silva et al. 2005). 
Genetic elimination of P2X2 and P2X3 eliminates taste responses in the 
gustatory nerves, although the nerves remain responsive to touch, temperature, 
and menthol.  Similarly, P2X-knockout mice show greatly reduced behavioral 
responses to sweeteners, glutamate, and bitter substances.  Loss of either P2X2 
or P2X3 alone resulted in only a moderate change in taste-mediated behaviors in 
contrast to profound deficit seen in P2X2/ P2X3 Dbl -/- (KO) animals.  Thus 
neither homomeric P2X2 or homomeric P2X3 suffice for normal function in the 
peripheral taste system (Finger et al. 2005). 
 
P2X4 
Long-term potentiation at Schaffer collateral synapses is reduced in mice 
lacking the P2X4 ATP receptor relative to that in wild-type mice (Sim et al. 2006).  
Knockout studies have also shown P2X4 currents are functionally expressed in 
recruited peritoneal macrophages of WT mice and that the P2X4-like current is 





 Although no studies of P2X5 knock out mice have been reported, it has 
been reported that the most common human allele for P2X5 produces a non-
functional protein (Bo et al. 2003), so it appears that many humans are 
homozygous for this null mutation.  It therefore appears that this subunit does not 
carry out an essential function in our species. 
 
P2X7 
Of the seven P2XR subunits (P2X1-7), the first six are expressed 
throughout the peripheral and central nervous systems.  The P2X7 purinoceptor 
is expressed predominantly by cells of hematopoietic origin (Chessell et al. 2005) 
and its expression has been demonstrated in microglial cells, granulocytes, 
monocytes/macrophages, and B and T lymphocytes.  P2X7 receptor protein is 
strongly and reliably detected in the submandibular gland and lung of wild-type 
mice but not in either of the P2X7-/- mice (Sim et al. 2004). 
Upon sustained activation, the P2X7 receptor forms large pores in the 
plasma membrane.  P2X7 was termed the cytolytic non-neuronal P2X receptor 
because it had not been detected in neurons until recently immunolocalized to 
several brain regions, particularly the hippocampus, where it might be involved in 
presynaptic modulation of transmitter release (Sim et al. 2004). 
In cells of hematopoietic origin, P2X7 receptors act not only as cationic 
channels but uniquely couple with multiple downstream events including rapid 
release of proinflammatory cytokines such as IL-1 beta, IL-6 and TNFalpha, 
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cytoskeletal rearrangements, cell permeabilization, and apoptosis or necrotic cell 
death.  P2X7 receptors are rapidly upregulated and activated in immune cells as 
a result of inflammatory stimuli, and have been involved in several cellular 
mechanisms including those related to inflammation and immunological response 
(Sim et al. 2004). 
Indeed mouse transgenic studies have established the P2X7 receptor as 
an important component of in vivo inflammatory, immunological, and nociceptive 
responses (Chessell et al. 2005).  Direct evidence for P2X7 function in 
inflammatory response has been reported on the effects on leukocyte function 
and macrophage infiltration (Labasi et al. 2002), and apoptosis in response to 
ureteral obstruction (Goncalves et al. 2006).  P2X7 receptors play a key role in 
the release of brain cytokine IL-1 beta in response to immune stimuli (Mingam et 
al. 2008) and have been shown to inhibit intracellular infection by chlamydiae and 
mycobacteria in macrophages (Darville et al. 2007).  ATP stimulation of cell 
surface P2X7 receptors results in cytolysis and cell death of macrophages (Le 
Feuvre et al. 2003). 
Knockout studies of P2X7 have provided direct evidence for a role of this 
receptor in the non-neuronal physiology of skeletal mechanotransduction (Li et 
al. 2005) and osteogenesis during skeletal development (Panupinthu et al. 2007), 
and the generation of multinucleated giant cells, polykaryons, and osteoclasts 
(Gartland et al. 2003).  The established regulatory roles in bone formation and 
resorption make the P2X7 receptor a novel therapeutic target for the 
management of skeletal disorders such as osteoporosis (Ke et al. 2003). 
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In parallel, P2X7 knockout studies of have provided some evidence for a 
role of this receptor in neuronal physiology as well.  Functional P2X7 receptors 
have been demonstrated to be present in synaptic terminals from midbrain of 
wild type mice (Marin-Garcia et al. 2008).  Further, P2X7 receptor -/- mice 
exhibited lack of ATP-evoked GABA and glutamate release in mouse 
hippocampal slices (Papp et al. 2004).  However, Sim and others failed to find 
evidence for P2X7 receptor protein in hippocampal neurons or their input-output 
projections (Sim et al. 2004). 
There is clearly an abundance of in vivo evidence to substantiate the 
importance of P2X receptors in the modulation of a broad range of physiological 
processes in excitable and nonexcitable cells.  It will be interesting to see if 
transgenic mouse models can aid in uncovering the physiological significance of 
heteromers involving P2X5 or P2X6 in cells where they are coexpressed with 
other P2XRs.  Also, knock in studies aimed at assessing the validity of functional 
attributes assigned to residues from conclusions reached in vitro are anxiously 
awaited. 
 
1.5 P2XR cross talk with other Ligand-Gated Ion Channels 
When LGICs of different families are coexpressed in cells, activation can 
result in one channel modulating the function of the other, and vice-versa.  This 
phenomenon is known as receptor cross-talk, and is usually manifest as non-
additivity of the respective individual responses.  That is, peak currents evoked 
by the respective agonists for each receptor are less than when only one of the 
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agonists is present.  Interactions between P2XRs and other LGICs coexpressed 
in nerve terminals could play a regulatory role by buffering the paracrine effects 
of ATP and other neurotransmitters on reflex actions. 
P2X2 and α3β4 nicotinic channels influence each other when coactivated 
in Xenopus oocytes and synaptically coupled myenteric neurons.  Coactivation 
results in non-additive responses owing to inhibition of both channel types.  Thus, 
ATP occludes synaptically activated nicotinic channels, and this may be relevant 
to the effects of ATP spillover from purinergic synapses, ATP released during 
local tissue damage, and ATP released during inflammation (Khakh et al. 2000).  
The functional cross-inhibition between ATP-gated channels and other excitatory 
transmitter-gated channels of the nicotinic receptor family may regulate neuronal 
excitability and synaptic plasticity by limiting both the level of depolarization and 
the flow of calcium ions through calcium-permeable P2X receptors.  Alternatively, 
in pathological conditions of neuronal hyperactivity, interchannel cross-talk may 
also play a protective role by preventing overexcitation and calcium-dependent 
excitotoxicity (Boue-Grabot et al. 2003). 
Concurrent activation of P2X2 ATP-gated channels and 5-HT3 serotonin-
gated channels leads to functional interaction and nonadditive currents in 
mammalian myenteric neurons as well as in Xenopus oocytes or transfected 
HEK293 cell heterologous systems.  These two cation channels were also shown 
to coimmunoprecipitate constitutively and to be associated in clusters (Boue-
Grabot et al. 2003). 
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Epithelial sodium channels (ENaC) coexist with P2X receptors in the renal 
collecting duct.  Coexpression studies in Xenopus oocytes showed that ENaC 
was downregulated by the activation of P2X2, P2X2/6, P2X4, and P2X4/6 
receptors.  Conversely, ENaC increased the plasma membrane expression of 
P2X2, P2X2/6, and P2X5 receptors (Wildman et al. 2005). 
Finally, activation of synaptically coupled neurons of the lateral 
hypothalamus elicits reliable and concurrent release of ATP with GABA (Jo & 
Role 2002).  Nonadditivity of P2X and GABAa-mediated currents has been 
observed in rat dorsal root ganglion neuron receptors, providing more evidence 
for nonindependence of activity between P2X and several members of the 
nicotinic receptor superfamily (Sokolova et al. 2001). 
P2X receptors, notably P2X7, form large pores that can mediate apoptotic 
cell death.  These megapores are non-selective cation channels that are inwardly 
permeable to large cations such as ethidium bromide and NMDG+.  Two 
alternate views to explain this variability in selectivity and magnitude of 
responses have been proposed.  The first holds that the megapore state is due 
to a change in the intrinsic channel gating properties, whereas the other invokes 
recruitment of accessory proteins as the mechanism underlying the dramatic 
changes in receptor characteristics.  Pannexin1 appears to be the molecular 
substrate for this permeabilization pore and dye-uptake pathway recruited into 
the P2X7 signaling complex in Xenopus oocytes and macrophages (Locovei et al. 
2007, Pelegrin & Surprenant 2006).  It remains to be demonstrated whether 
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pannexins or other hemichannels are required for megapore conductance in 
other P2X receptors. 
 
1.6 Heterologous expression in Xenopus oocytes and HEK293 cells 
Experiments by King and colleagues (2000) confirmed that there are 
difficulties associated with P2X6 receptor expression in Xenopus oocytes and in 
all probability, in other cell systems.  It is possible that Xenopus oocytes and 
most HEK293 cells fail to produce an essential protein necessary to insert P2X6 
subunits into the cell membrane.  One plausible candidate for this protein is 
another P2X subunit, perhaps the P2X2 or P2X4 subunits.  Functional 
heteromeric P2X2/6 are indeed formed and inserted into the membrane of 
Xenopus oocytes (King et al. 2000). 
 
2.0 Metals needed by living organisms 
There are fourteen metals currently known to be essential for plants and 
animals.  Four of these, sodium, potassium, magnesium and calcium, are 
present in large quantities and are known as bulk metals.  Nine of the remaining 
ten are d-block elements: vanadium, chromium, molybdenum, manganese, iron, 
cobalt, nickel, copper, and zinc.  Also of high significance is the non-metal 
selenium, which is in the same family of elements as oxygen (Alexander 2007).  
These ten species are present in small quantities and are known as the trace 
metals.  The bulk metals form 1-2% of the human body weight, whereas the trace 
elements represent less than 0.01%.  Concentrations of metals in cells are 
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strictly regulated at their respective optimum levels: too much or too little is often 
harmful and may even be lethal to the organism (Wilson et al. 2004). 
Most of the trace metals are found as obligatory constituents of a variety 
of proteins and vitamins.  More than 30% of all proteins in cells exploit one or 
more metals to perform their specific functions.  Metal-binding proteins fold in a 
cellular environment where their cognate cofactors are present, either free in the 
cytoplasm or bound to delivery proteins.  The bound metal causes energetic and 
structural effects on the folded protein, which in turn has consequences on 
function.  Thus, metals generally stabilize the folded forms of metalloproteins 
(Wilson et al. 2004). 
The amino acids that regularly act as metal ligands in proteins are 
thiolates of cysteines, imidazoles of histidines, and carboxylates of glutamic and 
aspartic acids (Maret 2006).  Each metal favors different sets of protein ligands.  
Due to the unique chemical properties of each metal, different metals are apt for 
different types of biological functions, although there is overlap in some cases 
(Wilson et al. 2004).  Several reports have shown that transition metals such as 
zinc and copper can modulate the ATP-evoked currents in P2X receptors. 
 
2.1 Biological roles of the bulk metal, calcium 
Calcium ions (Ca2+) impact nearly every aspect of cellular life (Clapham 
2007).  Calcium is the most abundant mineral in the human body where it plays a 
critical role in determining the strength and hardness of teeth and bone.  More 
than 99% of the total body calcium is stored in the bones and teeth where it 
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functions to support their structure.  The remaining 1% is found throughout the 
body in blood, muscle, and the extracellular fluid (Shils 1999). 
Non-structural Ca2+ localized outside of the hard tissues has multiple 
dynamic roles in cellular processes involving both rapid and sustained  cellular 
events.  Calcium is a critical regulating factor in a broad range of functions 
including cellular homeostasis (Wolfe & Pearce 2006), membrane excitability 
(Smith et al. 2003), cell cycle control (Munaron et al. 2004), cytoskeletal 
dynamics (Zheng & Poo 2007), and gene expression (Carrasco et al. 2004).  
Calcium is needed for contractility of smooth, skeletal, and cardiac muscle 
(Isojima & Bozler 1963, Frank 1964, Nayler 1966), blood vessel tone (Akata 
2007), regulated exocytosis (Penner & Neher 1988), and sending messages 
throughout the nervous system. 
A constant level of Ca2+ is maintained in body fluid and tissues so that 
these vital body processes function efficiently (Institute of Medicine (U.S.). 
Standing Committee on the Scientific Evaluation of Dietary Reference Intakes. 
1997).  When Ca2+ intake is low or Ca2+ is poorly absorbed, bone breakdown 
occurs because the body must use the Ca2+ stored in bones to maintain normal 
biological functions such as nerve and muscle function.  Disease processes 
associated with calcium deficiency, or hypocalcemia, include: hypertension, 
cancer, kidney stones, obesity and related adverse health outcomes (Shils 
1999). 
Ca2+ movements across the cell membrane and between various 
intracellular compartments play a major role in the regulation of neuronal 
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excitability and neurotransmitter release (Smith et al. 2003).  Activation of P2XRs 
produces fast excitatory responses which can support membrane depolarization 
(Bertrand & Bornstein 2002) and influx of extracellular calcium in sensory and 
autonomic neurons (Surprenant 1996) and other cell types expressing P2XRs 
(Egan & Khakh 2004).  For example, in cultured rat myenteric neurons, ATP 
mainly activates ionotropic P2X2 receptors, resulting in an increase in intracellular 
calcium dependent on external calcium rather than internal stores (Ohta et al. 
2005).  P2X receptor activation causes the accumulation of calcium ions in the 
cytoplasm, which is responsible for activating numerous signaling molecules (Erb 
et al. 2006).  Thus, P2X receptors have the potential to modulate numerous 
cellular events that are regulated by transient or sustained changes in 
intracellular Ca2+ in cells expressing these ATP-gated channels. 
 
2.2 Biological roles of the trace metal, zinc 
The essential metal zinc (Zn2+) is the second most abundant trace metal in 
the body after iron, and is found in almost every cell.  Zinc is physiologically 
important for all organisms because it is a catalytic and/ or structural cofactor for 
numerous zinc-dependent enzymes and proteins.  Zinc supports a healthy 
immune system (Solomons 1998), helps maintain one’s sense of taste and smell 
(Heyneman 1996), is needed for wound healing and for nucleic acid synthesis 
(Barceloux 1999).  Zinc also supports normal growth and development during 
pregnancy, childhood, and adolescence (Fabris & Mocchegiani 1995, Simmer & 
Thompson 1985).  Zinc is not only an important cofactor of numerous enzymes 
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and transcription factors, but it also acts as an intracellular mediator, similarly to 
calcium.  As a result of efficient homeostatic control, zinc does not accumulate in 
excess (Zatta et al. 2003). 
Zinc has particular biological roles in some specialized cells.  Examples of 
biological roles for Zn2+ include the regulation of gene expression and cellular 
signal transmission (Zatta et al. 2003).  Zinc is stored in pre-synaptic terminals 
and released upon nerve stimulation (Palmiter et al. 1996) where it acts as a 
paracrine signaling molecule and regulator in pancreatic cells and neurons by a 
mechanism of vesicle-mediated metal excretion and uptake (Chimienti et al. 
2003). 
Zinc has been shown to act as an endogenous modulator of excitatory 
and inhibitory ligand-gated ion channels, and some members of the voltage-
gated-like ion channel superfamily (Mathie et al. 2006).  Zinc can be stored with 
either glutamate or GABA, respectively the main excitatory and inhibitory 
transmitters in the brain (Beaulieu et al. 1992).  Although Zn2+ affects most 
LGICs, to date putative zinc-binding sites have been identified in the subunits of 
NMDA, GABAa and GABAc receptors, GlyRα1, ASICs, P2XRs, and nAChRs as 
well as P2XRs. 
GlyR activated currents are potentiated by zinc at low concentrations, and 
are inhibited by zinc at higher concentrations.  Aspartate-80 has been implicated 
in the potentiating zinc binding site, because the D80A mutation abolished 
potentiation, while inhibition was unimpaired (Lynch et al. 1998).  The E110A 
mutation reduced sensitivity to zinc inhibition by 16-fold, indicating it could be a 
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coordinating residue for zinc either directly or through a water molecule.  
Although zinc bound within proteins is normally coordinated by at least 3 side 
chains, coordination by only 2 residues may be sufficient to explain the relatively 
low binding affinity of the inhibitory zinc-binding site (Nevin et al. 2003). 
A knock in study was successfully accomplished for the glycine receptor 
(GlyR) alpha1 subunit gene (Glra1), to test the in vivo relevance of Zn2+ 
neuromodulation by producing knock in mice carrying the mutation D80A in 
Glra1.  Homozygous Glra1(D80A) mice developed a severe neuromotor 
phenotype, hyperekplexia (startle disease).  In spinal neurons and brainstem 
slices, GlyR expression, synaptic localization, and basal glycinergic transmission 
were normal; however, potentiation of spontaneous glycinergic currents by Zn2+ 
was significantly impaired (Hirzel et al. 2006). 
Several lines of evidence indicate that zinc and other divalent cations 
coexist with ATP or P2X purinoceptors in central and peripheral neuronal 
regions.  For example, zinc is abundant in hippocampal nerve endings, and RNA 
from P2X4 is highly expressed in this region.  Zn2+ potentiates ATP-evoked 
responses in rat PC12 cells, and in some mammalian peripheral neurons, 
apparently by increasing the sensitivity to ATP, but not by increasing the maximal 
responses (Nakazawa & Ohno 1997).  The P2X2 receptor is modulated by zinc in 
a reversible fashion that is dependent on both the ATP and zinc concentrations 
and is voltage independent (Lustig et al. 1993, Wildman et al. 1998). 
Extracellular zinc reaches concentrations in the high micromolar range 
during neuronal activity and thus may physiologically regulate ATP-P2X receptor 
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interactions in the hypothalamus (Vorobjev et al. 2003).  The proximity of 
synaptic zinc to P2X receptors and the coincident timing of release with 
endogenous agonist ATP suggests that zinc could affect ATP-evoked responses 
in vivo. 
In contrast to the redox-active metals iron and copper that participate in 
electron transfer reactions of photosynthesis and/ or respiration, redox-inactive 
zinc serves as a superacid center in several metalloenzymes, promoting 
hydrolysis or cleavage of a variety of chemical bonds.  Representative proteins 
that use catalytic zinc ions are carboxypeptidases, carbonic anhydrase, and 
alcohol dehydrogenase.  In addition, zinc ions play structural roles in zinc-finger 
(ZF) motifs and proteins such as superoxide dismutase.  Most ZFs serve as 
DNA-binding domains in proteins that regulate gene expression.  However, 
recent work has demonstrated that ZFs can also mediate protein-protein and 
protein-lipid interaction (Wilson et al. 2004). 
The classic ZF motif is a peptide comprised of ~30 residues that is folded 
around a divalent zinc cation.  Cysteine and/ or histidine residues provide the 
side chains that coordinate Zn2+, most often in a tetrahedral geometry.  Raman 
spectroscopy experiments have shown that when both histidine and cysteine are 
present, cysteine residues bind to the Zn2+ prior to coordination of the histidines.  
Conserved hydrophobic residues as well as the spacing between the zinc ligands 
further contribute to the ZF’s metal binding characteristics.  The zinc binds tightly; 
the dissociation constant for a typical ZF-Zn2+ complex is ~10 pM.  Nuclear 
magnetic resonance and circular dichroism experiments have demonstrated that 
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modification or elimination of the zinc ligands, or the conserved hydrophobic 
residues, in ZF peptides strongly affect metal affinity (Wilson et al. 2004).  None 
of the known consensus sequences for ZF or metalloenzymes are present in the 
P2X receptors (Ennion et al. 2001). 
 
2.3 Pathologies of Zn2+  dysregulation 
Excess zinc can be cytotoxic, and zinc transporters as well as 
metallothioneins serve as zinc detoxification systems (Chimienti et al. 2003).  
There has as yet been no evidence that zinc is directly involved in the etiology of 
neurodegenerative diseases in humans.  However, the concentration of free zinc 
and copper either in the synaptic cleft or neuronal cytoplasm may contribute to 
the etiology of certain disease states such as Alzheimer's disease (AD) and 
epilepsy.  Hence, zinc appears to be a contributing factor in the progression of 
senile plaque formation in the brains of patients with AD (Mathie et al. 2006), and 
epileptic brain damage caused by neuronal injury induced by the excessive 
release of endogenous Zn2+ at central glutamatergic synapses (Koh & Choi 
1994). 
The amyloid β (Aβ) peptide is the major constituent of senile plaques.  
Deposition in the brain of insoluble aggregates of Aβ causes neurodegeneration.  
Several studies have shown that Cu2+ and Zn2+ promote aggregation of Aβ in 
vitro.  In vivo, high concentrations of Cu2+ (0.4 mM) and Zn2+ (1 mM) have been 
reported in aggregates isolated from diseased brains.  Zn2+ ions induce Aβ  
aggregation at pH >6, whereas Cu2+ is only effective between pH 6 and 7. 
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Raman spectroscopy and NMR have demonstrated that three histidines 
situated in the N-terminal hydrophilic region constitute the primary metal-binding 
sites.  Upon Zn2+ binding to one histidine, peptides aggregate through 
intermolecular His-Zn2+-His bridges.  The same mechanism is proposed for Cu2+ 
induced Aβ aggregation (Wilson et al. 2004). 
Conformational changes of metallopeptides play an important role in a 
range of human diseases.  Further understanding of metallopeptide and 
metalloprotein folding may also aid in curing of diseases related to metal 
metabolism, such as Menkes syndrome and Wilson’s disease, which both involve 
erroneous cofactor-protein interactions (Wilson et al. 2004). 
 
2.4 Residues necessary for Zn2+ and pH modulation of rP2X2 receptors 
Previous reports have shown that extracellular pH and divalent zinc are two 
endogenous modulators that differentially affect the seven P2X receptor 
subtypes that have been cloned from rat (Stoop et al. 1997, Wildman et al. 
1998).  For example, extracellular zinc (<100 μM) potentiates the responses of 
homomeric P2X2, P2X3, P2X4, and heteromeric P2X2/6, and P2X4/6 receptors.  In 
contrast, the responses of P2X1 (Wildman et al. 1999b) and P2X7 (Virginio et al. 
1997) are inhibited in the same range of zinc concentration.  Since P2X receptors 
on sensory neurons include P2X2 subunits, the attendant acidosis and ATP-
release associated with tissue injury may play a role in sensitizing sensory nerve 
fibers (Wildman et al. 1997).  Proton and zinc modulation have both been 
suggested to occur by allosteric regulation of the P2X receptors rather than by an 
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effect on ATP, because changes in the species of ATP present do not correlate 
with changes in receptor modulation properties (Clyne et al. 2002a). 
Histidine residues are prominent in the zinc-binding domains of many 
structural proteins, transcription factors, and enzymes.  Also, histidines are 
essential for the zinc sensitivity of GABA, NMDA, and Glycine receptors.  Our lab  
showed that mutating histidine-319 of rP2X2 greatly reduced pH potentiation with 
no effect on zinc modulation (Clyne et al. 2002a).  In contrast, mutating either 
one of two histidines (H120 or H213) to an alanine nearly eliminated zinc 
potentiation without altering pH modulation.  Mutations at H120 and H213 do not 
dramatically alter the response to ATP, suggesting that these mutations do not 
dramatically disrupt receptor gating.  Further, it was shown that zinc potentiation 
of P2X2 responses to 10 μM ATP attenuates at zinc concentrations greater than 
100 μM.  Zinc inhibition was maintained in H120A and H213A suggesting that 
there are independent, low and high-affinity sites that mediate inhibition and 
potentiation, respectively. 
In most zinc-binding proteins, zinc complexes with either three or four 
residues (Maret 2006).  Loss of one or more of the zinc-coordinating side chains 
likely reduces the affinity of the binding site.  Thus, with respect to potentiation, 
zinc is probably coordinated by one or two residues in addition to H120 and 
H213. 
It has been shown by Nagaya et al. (2005) that these coordinating histidines 
originate from adjacent P2X2 subunits, instead of from the same subunit. 
Assuming the intersubunit binding site is tetrahedral, the coordinating residues 
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might consist of two H120 and two H213 residues, or consist of H120 and H213 
residues from different subunits, and one or two as yet unidentified residues 
contributed from one subunit or adjacent subunits.  The first possibility is unlikely 
because that would predict that only one zinc binding site for potentiation is 
present for each trimer of subunits.  Concatemeric constructs have been used to 
show that there are up to three intersubunit sites for the high-affinity coordination 
of zinc, and that sequential removal of each one results in progressive decreases 
in potentiation to zinc (Nagaya et al. 2005). 
In studies parallel to those of Clyne and colleagues (2002a), complete metal 
concentration curves were used by Lorca and others (2005), to investigate the 
role of extracellular histidines in metal modulation of rP2X2.  To assess the role of 
residues in zinc modulation, assays were performed to compare fold potentiation 
vs. ascending concentrations of zinc while holding ATP concentration at the 
EC10.  The results of their screen confirmed the original observations of Clyne et 
al. (2002a), that H120 and H213 are required for the modulator action of zinc at 
the high-affinity metal coordination site.  However, unlike the results reported in 
the original histidine scan by Clyne et al. (2002a), Lorca and colleagues claim 
that residues H192 and H245 may also participate in the modulator action of 
zinc.  While WT exhibited 6-7 fold potentiation under the conditions used, H192A 
and H245A exhibited potentiation of approximately two-fold.  As not all mutants 
resulted in an equal phenotype for zinc or other trace metals, they proposed that 
these histidines form part of a metal-binding pocket, where each metal 
coordinates differentially and with varying affinity to these and/or to additional 
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amino acid residues.  Because of these phenotypic differences, the authors 
propose a model where Zn2+ is coordinated in a complex involving H120, H213, 
H245, and further stabilized in an auxiliary role by the more distant H192. 
Lorca and colleagues used 10 μM ATP, which is the EC10 value they report 
for the WT receptor expressed in Xenopus laevis oocytes.  For the H245A 
mutant, they used 1 μM ATP because the ATP concentration-response curve 
they obtained in characterization of this mutant was left-shifted compared to WT.  
Our lab has not been able to replicate the report that the H245A mutant is left-
shifted.  Our data show that both H192A and H245A are slightly right-shifted 
relative to WT.  Further, our lab has not been able to reproduce results that 
support the claim that H245 and H192 are involved in Zn2+-potentiation. 
 
3.0 Site-directed mutagenesis studies of P2X receptors 
There are predictions that one can make regarding the functional roles of 
conserved and unconserved residues.  On the one hand conservation of a 
residue at a given position in a family of related subunits likely indicates that the 
residue has a structural or functional role.  On the other hand, properties that 
vary among the family members such as sensitivity to protons and Zn2+ are likely 
due to unconserved amino acids. 
Site-directed mutagenesis has been used to identify residues of general 
importance to channel function.  Briefly, phosphorylatable intracellular residues 
have been shown to regulate channel gating and kinetics, transmembrane 
residues have been shown to affect ionic permeation; and extracellular residues 
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have been shown to be important for ligand binding, glycosylation and trafficking, 
gating, desensitization and allosteric modulation (Evans 2008). 
 
3.1 Charged extracellular residues 
There are eleven aspartate (D) and glutamate (E) residues in hP2X1 that 
are conserved among the seven family members of hP2XRs.  Ennion et al. 
(2001) examined the role of the conserved negatively charged D and E residues 
within the ECD of human P2X1 by alanine-scanning mutagenesis.  Of the eleven 
residues tested for effects on ATP potency and cell surface localization, no major 
shifts in EC50 values were observed.  Their results showed that individual 
conserved negatively charged amino acids are not essential for ATP recognition 
by hP2X1, and coordinated binding of the positive charge on Mg2+ complexed 
ATP by negatively charged amino acids is not required.  The most striking 
change observed in P2X1 receptor phenotype was a pronounced (~90%) 
decrease in current amplitude for the D86A and D264A mutants.  Possible 
explanations for these results are 1) altered gating capability, or 2) decreased 
cell surface expression of the mutant channels.  Evidence supporting the latter 
hypothesis was obtained in biotinylation experiments, verifying that decreased 
receptor expression accounts for the lack of functional receptors in cells 
transfected with mutants E85A and D261A.  Conservative mutation of charge 
and shape of amino acid side chain at these positions is able to compensate for 
an aspartate residue at positions 86 and 264 (Ennion et al. 2001). 
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 Little or no change in ATP potency was seen at individual point mutations 
to replace negatively charged glutamate or aspartate residues at P2X1 receptors; 
a similar pattern was seen on a P2X2 receptor background with the exception of 
an ~100-fold decrease in ATP potency at the D259A mutant and no responses 
were detected for E85A and D261A mutant P2X2 receptors.  Interaction of 
conserved and non-conserved amino acids may play a role in regulation or fine-
tuning of channel properties (Roberts et al. 2006). 
 
3.2 Uncharged extracellular residues 
 Uncharged polar amino acids can also contribute to ligand action at 
receptors either by hydrogen bonding with the agonist or stabilizing structural 
changes.  Non-polar aromatic amino acids have also been shown to be involved 
in ATP binding at a range of proteins.  Extracellular P2X1 receptor residues F185 
T186 and N290 F291 R292 could be involved in coordinating the binding of the 
adenine ring of ATP (Roberts et al. 2006).  Tyrosine residues are candidates for 
zinc coordination because of the known ability of the Π faces of aromatic rings to 
bind positive charges (Lynch et al. 1998). 
Studies on the inhibitory zinc binding site of the GlyRα1 subunit have 
shown that in addition to histidines 107 and 109, threonine-112 appears to have 
a significant structural role in the zinc binding site but may have an additional 




3.3 Non-polar extracellular residues 
Conserved proline and glycine residues are also of interest, as these may 
give some structural restraint to the receptor through the introduction of 
kinks/tight turns in the protein or introduction of flexibility, respectively.  Proline 
imino amino acids can introduce particular structural features to proteins.  
Generally, peptide bonds between two amino acids in proteins are planar and 
trans.  However, proline residues can form cis peptide bonds.  Cis/ trans 
isomerization can therefore lead to reversible conformation changes and prolines 
can act as hinges in transmembrane α-helices.  The lack of a hydrogen bond 
donor makes proline a classical breaker of α-helical structure.  Proline can also 
promote folding and is frequently associated with β-turns.  Thus, proline residues 
in the extracellular loop may be essential for structural integrity or involved in 
ATP action or allosteric modulation.  Early reports suggested that conserved 
proline and glycine residues in the extracellular loop do not appear to play an 
essential role in ATP action at the P2X1 receptor (Roberts et al. 2006). 
The extracellular domain of hP2X2 receptors contains four prolines that 
are totally conserved across the P2X receptor family (P93, P166, P228, and 
P272) and three less conserved residues (P196, P174, P225) and P330 (hP2X1) 
conserved in all rat and human isoforms except for the P2X7 and hP2X5 receptor.  
Amino acid substitution at P272 indicated that this residue contributes to ATP 
action.  Replacement with either alanine, aspartate, or lysine abolished channel 
function.  In contrast, isoleucine substitution at P272 had essentially no effect 
whereas replacement with glycine or phenylalanine increased ATP potency.  This 
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region of the receptor is very sensitive to amino acid substitution, indicating that it 
may play an important structural role in channel function.  The effects of mutation 
at P272 were dependent on the amino acid substitution indicating that the 
conformation at this region of the receptor contributes to the ATP action at the 
P2X1 receptor (Roberts & Evans 2005). 
Extracellular glycine residues are also important for the function of some 
P2X receptors.  When expressed in Xenopus oocytes, P2X1 serine substitution at 
glycine 250 produced receptors that gave functional responses to ATP with no 
effect on ATP sensitivity but a reduction in peak amplitude; in contrast, functional 
responses were not recorded when glycine 250 was replaced by the amino acids 
alanine, cysteine, aspartate, phenylalanine, isoleucine, lysine, proline or 
asparagine.  These results suggest that glycine 250 plays an important role in 
determining the function of P2X receptors. 
In the cloned P2X2 channel, responsiveness to ATP was lost when Gly247 
was replaced by alanine.  The sensitivity to ATP was reduced when Gly248 was 
replaced by alanine, and the responsiveness to ATP was lost when Gly248 was 
replaced by valine.  The results suggest that the neighboring glycine residues 
(G247-G250) are essential for P2X2 receptor function (Nakazawa & Ohno 1999). 
 
3.4 Extracellular cysteine residues 
Cysteines form essential components of metal ion binding sites in many 
proteins (e.g. zinc finger motifs and metalloenzymes).  There are ten conserved 
cysteines in the extracellular loop of P2X receptors.  The role of conserved 
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extracellular cysteine residues in the function of P2X2 and the modulation of its 
responses to ATP by pH and zinc has been investigated previously (Clyne et al. 
2002).  Although mutation of many of these conserved cysteines resulted in 
changes in zinc modulation, it was inferred that the action was indirect. Rather 
than playing a role in binding zinc, the cysteine residues form disulfide bonds 
(DSBs), and breaking these bonds results in the structural changes that might 
account for the reduced effects of zinc.  Disulfide bonds are known to play an 
important role in the formation and maintenance of ion channel structure. 
Until recently, it was widely believed that all ten cysteine residues in the 
rP2X2 ECD are disulfide bonded because the receptor fails to label in the 
presence of MTS reagents.  Now there is evidence that a cysteine residue of the 
P2X4 receptor is critical for the modulator role of zinc.  This suggests that the 
cysteine residue in question does not form a disulfide bridge with other cysteines 
as has been suggested for other P2X subtypes (Coddou et al. 2007), while also 
asserting that a second extracellular cysteine remains unpaired. 
To gain insight into the folding/ structural organization of the extracellular 
loop, Ennion and Evans sought to determine effects on ligand binding, surface 
expression, and ATP potency, and existence of free cysteines in the P2X1 
extracellular domain (Ennion & Evans 2002).  Disruption of two bonds (C261 - 
C270 and C217 – C227) results in >90% decrease in peak current, but little to no 
effect on ATP potency and time-course of response.  Notably, C261A and C270A 
mutations resulted in inefficient trafficking of P2X1 receptors to the cell surface, 
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suggesting that these bonds confer important tertiary structure (Ennion & Evans 
2002). 
Although known to stabilize individual subunits, DSBs can also form 
between subunits, supporting oligomerization.  Cysteine residues can also 
contribute to stabilization of quaternary structure when liganding zinc between 
different polypeptide chains termed, protein interface zinc sites (Messerschmidt 
2001). However, multiple investigators have produced evidence that there are no 
intersubunit disulfide bonds in wild type P2X receptors. 
 
4.0  The role of negatively charged extracellular residues in allosteric 
modulation by pH and zinc of the rat P2X2 receptor 
 
4.1 Specific Aim 1 
We used site-directed alanine-scanning mutagenesis and two-electrode 
voltage clamp recording of mutant channels heterologously expressed in 
Xenopus oocytes to test if any of the 34 aspartate (D) and glutamate (E) residues 
of the P2X2 extracellular domain were individually required for channel function 
and potentiation or inhibition of channel activity by zinc.  The rationale for this 
approach was that given the residues that had already been tested, they were 
the most likely remaining candidates.  Characterizing these mutants also 
provided the opportunity to test if they play a more general role in channel 
function.  Negatively charged residues might coordinate Mg2+ATP, or they might 
interact with the positively charged residues in the adenine moiety of ATP, and 




4.2 Specific Aim 2 
P2X2 receptors can be modulated by protons (Wildman et al. 1997).  Prior 
studies in our lab have shown that P2X2 histidine 319 is required for wild type-like 
pH potentiation.  None of the other extracellular histidine or cysteine residues are 
required for potentiation by protons, so some mechanism to account for the 
residual pH potentiation in the H319A mutants remains to be discovered. 
Because acidic residues have been reported to bind protons in other 
ligand-gated ion channels such as cyclic nucleotide-gated channels and the VR1 
capsaicin receptor, it is plausible that they contribute to pH potentiation of P2X2.  
Therefore, I tested the hypothesis that negatively charged residues of the P2X2 
extracellular domain act to coordinate protons at sites for pH potentiation by 






















Figure 1.1  Schematic diagram of the membrane topology and key residues 
of rat P2X2 receptors.
 
P2X2 receptors function as homotrimers.  The full length of one of the 
subunits (black) is shown with pieces of the two neighboring subunits (gray) that 
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Contribution of extracellular negatively charged residues to ATP 
action and zinc modulation of rat P2X2 receptors 
 
Abstract 
Two histidines are known to be essential for zinc potentiation of rat P2X2 
receptors, but the chemistry of zinc coordination would suggest that other 
residues also participate in this zinc binding site.  There is also a second lower 
affinity zinc binding site in P2X2 receptors whose constituents are unknown.  To 
assess whether extracellular acidic residues of the P2X2 receptor contribute to 
zinc potentiation or inhibition, site-directed mutagenesis was used to produce 
alanine substitutions at each extracellular glutamate or aspartate.  Two electrode 
voltage clamp recordings from Xenopus oocytes indicated that 7 of the 34 
mutants (D82A, E85A, E91A, E115A, D136A, D209A, and D281A) were deficient 
in zinc potentiation and one mutant (E84A) was deficient in zinc inhibition.  
Additional tests on cysteine mutants at these 8 positions indicated that D136 is 
the only residue that is a strong candidate to be at the potentiating zinc binding 




The divalent cation zinc is found in the mammalian central nervous system 
either tightly bound to proteins or as a smaller pool of free, chelatable zinc 
(Cuajungco & Lees 1997, Zatta et al. 2003).  Genetic deletion of the zinc 
transporter ZnT3 in mice results in a dramatic decrease in the amount of zinc that 
can be detected in synaptic terminals but produces no obvious change in the 
behavior of mice (Palmiter et al. 1996, Cole et al. 1999, Salazar et al. 2005).  
Despite this observation, there is considerable evidence in support of the idea that 
synaptically released zinc plays a role as a regulator of synaptic transmission in 
the brain (Li et al. 2003).  The most direct in vivo evidence for zinc as a 
physiological modulator in the brain is the observation that mice that express a 
mutant form of the glycine receptor α1 subunit gene (Glra1) that is zinc 
insensitive, but fully responsive to glycine, show a dramatic startle-prone 
phenotype, hyperekplexia (Hirzel et al. 2006). 
In addition to modulating the activity of glycine receptors in vivo, in vitro 
studies indicate that extracellular zinc can potentiate or inhibit the current 
responses of nicotinic acetylcholine receptors (Hsiao et al. 2001, Hsiao et al. 
2006); NMDA receptors (Forsythe et al. 1988, Rassendren et al. 1990); and 
GABA type A receptors (Gibbs et al. 2000).  It has also been shown that zinc 
potentiates ATP-activated currents in many cell types including rat sympathetic 
neurons (Cloues et al. 1993), rat nodose ganglion neurons (Wright & Li 1995), 
and acutely isolated rat hypothalamic neurons (Vorobjev et al. 2003).  ATP 
released from cells can function as a synaptic neurotransmitter, an autocrine 
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signal, or a paracrine signal in a wide range of mammalian tissues (Ralevic & 
Burnstock 1998, Stojilkovic & Koshimizu 2001).  This signaling is mediated by 
ionotropic P2X receptors (P2XRs) and G-protein-coupled P2Y receptors.  
Because ATP and zinc are both released from some neurons in an activity-
dependent manner (Wright & Li 1995), it is plausible that neurotransmission at 
P2X utilizing synapses is modulated in vivo by zinc. 
The P2X receptor family consists of seven genes (P2X1-X7) and the 
proteins they encode function as homomeric or heteromeric oligomers of three 
subunits (North 2002).  Each P2X subunit has a short intracellular amino 
terminus, a first transmembrane domain, a large extracellular domain, a second 
transmembrane domain and a carboxy terminal domain of diverse length among 
subunits (Fig. 1).  With respect to P2X2 receptors, zinc exerts a concentration-
dependent biphasic modulation that is thought to result from an increase in ATP 
affinity at low concentrations of zinc, and a voltage-independent inhibition that 
reduces the efficacy of channel opening at high concentrations of zinc (Wildman 
et al. 1998, Clyne et al. 2002a, Vorobjev et al. 2003).  It has been shown 
previously by alanine-scanning mutagenesis that two extracellular histidines, 
H120 and H213, are required for zinc potentiation of P2X2 (Clyne et al. 2002a).  
Furthermore, the coordination of zinc by P2X2 has been shown to occur at the 
interface between adjacent subunits (Nagaya et al. 2005).  Prior studies on zinc 
finger transcription factors and metalloenzymes have shown that zinc is typically 
coordinated in a tetrahedral configuration that requires nitrogen, oxygen, and 
sulfur ligands from the side chains of histidine, aspartate, glutamate, or cysteine 
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residues (Maret 2005).  All of the extracellular histidines (Clyne et al. 2002a) and 
cysteines (Clyne et al. 2002) of P2X2 have already been tested for their potential 
role in zinc potentiation.  Therefore, in the current study we tested whether 
negatively charged residues of the P2X2 extracellular domain are structural 





Rat P2X2 cDNA (encoding a 472-amino acid protein) in pcDNA1 was 
obtained from Dr. D. Julius (University of California, San Francisco, CA).  The 
mutations were generated using the QuikChange site-directed mutagenesis kit 
(Stratagene, La Jolla, CA).  The sequences of mutant subunits were confirmed by 
DNA sequencing (University of Michigan DNA Sequencing Core).  Each mutant is 
referred to by the original amino acid (one-letter code) followed by the residue 
number and the substituted amino acid (one-letter code). 
 
Expression of P2X2 Receptors 
P2X2 receptors were expressed in defolliculated stage V-VI Xenopus laevis 
oocytes.  Oocytes were harvested using procedures approved by the University of 
Michigan Committee on the Use and Care of Vertebrate Animals and have been 
described in detail previously (Zhou & Hume 1998).  RNAs encoding wild type and 
mutant P2X2 receptors were synthesized using the mMessage mMachine T7 kit 
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(Ambion, Austin, TX).  Each oocyte was injected with 50 nl of RNA at 100–150 




Two-electrode voltage clamp experiments were performed 2–5 days after 
RNA injection.  All of the recordings were made at a holding potential of -50 mV.  
Recording electrodes were pulled from thin-walled borosilicate glass on a model 
P-87 Flaming Brown puller (Sutter Instrument Company, Novato, CA) and had 
resistances of 0.5–1 MΩ.  The currents were recorded with a Turbo TEC-03 
voltage clamp amplifier (npi electronic GmBH, Tamm, Germany).  Data acquisition 
was performed using a Digidata 1322A interface controlled by pCLAMP 9 
(Molecular Devices, Union City, CA). 
 
Materials 
[2-(trimethylammonium) ethyl] methanethiosulfonate bromide (MTSET) and 
sodium (2-sulfonatoethyl) methane thiosulfonate (MTSES) were obtained from 
Toronto Research Chemicals.  All other chemicals were obtained from Sigma. 
 
Solutions 
The external recording solution contained (in mM): 90 NaCl, 1 KCl, 1.3 
MgCl2, and 10 HEPES, pH 7.5.  Electrodes were filled with an internal solution of 
3 M KCl.  Disodium ATP was prepared as a 100 mM stock in double-distilled H2O 
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and stored at -20 °C.  For recording, ATP solutions were made by diluting the 
stock in external recording solution.  ATP solutions with concentrations of 200 µM 
and above were supplemented with MgCl2 to account for chelation of Mg2+ by 
ATP.  The amount to add to each concentration of ATP was calculated using 
Bound and Determined (Brooks & Storey 1992) so that the free magnesium 
concentration was 1 mM.  The ATP concentrations of recording solutions were 
verified by spectroscopic measurement at 259 nm (using an extinction coefficient 
of 15.4*103 M-1cm-1).  Zinc chloride was prepared as a 100 mM stock in double-
distilled H2O that was acidified with 0.01 M HCl to prevent precipitation.  The pH 
of ATP solutions with and without zinc was adjusted to 7.5 prior to recording.  For 
experiments assaying pH potentiation, the pH of ATP solutions to be tested was 
adjusted to 6.5 prior to recording.  All ATP recording solutions were used within 48 
hours. 
The sulfhydryl-reactive reagents MTSET and MTSES were prepared as 1 
M stocks in dimethyl sulfoxide and stored in 10-µl aliquots at -20 °C.  For 
recording, the stocks were diluted in the standard HEPES-buffered external 
recording solution to a working concentration of 1 or 10 mM.  For each incubation, 
50 µl of the working solution was added to the recording chamber with flow 
through the chamber stopped.  After incubation for 1-2 minutes, the oocytes were 
washed in external recording solution for one minute, and then assayed with the 
same protocol used before treatment.  This was repeated until there was no 




Quantification of Zinc Modulation and Selection of Zinc and ATP Concentrations 
 
The response of P2X2 receptors to zinc is biphasic; at low levels, zinc 
causes potentiation, but at high levels it results in inhibition of current (Wildman et 
al. 1998).  In a previous study, we used the non-potentiating mutants H120A and 
H213A to demonstrate that these two effects of zinc are separate processes.  At a 
zinc concentration of 20 µM or below, the inhibition is negligible, whereas at all 
higher zinc concentrations both processes are occurring (Clyne et al. 2002a).  We 
therefore used 20  µM zinc in all experiments testing only zinc potentiation, even 
though 50 and 100 µM zinc produce greater potentiation. 
To compare the magnitude of zinc potentiation between groups of oocytes, 
it is essential that all of the oocytes be studied at similar points on the ATP 
concentration response relation, because as the concentration of ATP increases, 
potentiation decreases so that there is no zinc potentiation when a saturating 
concentration of ATP is present (Wildman et al. 1998).  Furthermore, the EC50 for 
ATP of different oocytes expressing the same construct can vary significantly 
(Clyne et al. 2003).  We dealt with these complications by testing each oocyte with 
both a low concentration of ATP which we expected would be close to the EC10 
based on the average concentration response relation for each construct, and 
with 1,000 µM ATP, a maximal concentration for all constructs used in this study.  
Only data from oocytes for which it was verified that the low ATP concentration 
used was between the EC5 and the EC15 (so that at least a 6-fold increase in 
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current was possible) were analyzed.  All currents were measured after the 
responses had come to a steady state. 
To test for zinc potentiation, oocytes were given low ATP followed by low 
ATP plus 20 µM zinc.  We defined potentiation to 20 µM zinc as [(current in low 
ATP plus 20 µM zinc/ current in low ATP) -1].  Thus, a cell that showed no 
increase in current in response to zinc had zinc potentiation equal to 0, and a cell 
inhibited by 20 µM zinc had negative zinc potentiation. 
We followed a similar approach to test for zinc inhibition phenotypes.  
Oocytes were given low ATP plus 20 µM zinc followed by low ATP plus 1,000 µM 
zinc.  Zinc inhibition was defined as [1-(current in low ATP with 1000 µM zinc/ 
current in low ATP with 20 µM zinc)] %.  Therefore, a construct unresponsive to 
high zinc would have 0% inhibition, a construct in which 1,000 µM zinc potentiated 
more than 20 µM zinc would have negative inhibition, and a construct in which 




Data were analyzed using Clampfit and Microsoft Excel.  Error bars shown 
in all figures are the standard error of the mean (SEM).  The significance of 
differences between experimental conditions was tested using the student’s t test 
function of Excel.  When the same oocyte was tested before and after some 
treatment, the paired t test was used, while when groups of oocytes were 
compared with each other the unpaired t test was used.  To minimize the 
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possibility that with so many mutants compared to the wild type apparent 
significance might arise based on chance alone, significance was taken to be 
p<0.01. 
Concentration response relations for ATP were fit to the three parameter 
Hill equation using the nonlinear curve fitting program of Sigmaplot 9.0 (Systat 
Software Inc., San Jose, CA).  For displaying average concentration response 
data, the points from each oocyte were normalized to between 0 and 100% based 
on the maximum value of the fitted curve.  The scaled data were then averaged 
and plotted with error bars indicating the standard error of the mean.  The lines fit 
to the data indicate the average parameters of the individual fits. 
 
Results 
When voltage clamped at -50 mV, oocytes expressing all 34 of the P2X2 
mutants tested (Fig. 2.1) responded to 100 µM ATP with readily detectable inward 
currents.  Concentration response relations were assessed by giving an 
ascending series of ATP concentrations without intervening washes (Fig. 2.2A, B), 
and the data were fit to the Hill equation (Fig. 2.2C).  All shifts in the EC50 were 
less than 10-fold (Table 1).  The mutant receptor E85A showed the greatest 
rightward shift in EC50 (about 5-fold), and the mutant receptor D315A showed the 
greatest leftward shift in EC50 (about 6.5-fold, Fig. 2.2B).  In addition to changes in 
EC50, some mutants showed Hill coefficients that were somewhat larger or smaller 
than wild type.  We did not explore the mechanisms that caused these changes 
because there was no apparent correlation between having an altered Hill 
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coefficient or EC50 and having a change in the ability to respond to zinc (Table 1).  
To determine the maximum response that each construct could produce when 
saturating levels of RNA were injected, we used 1,000 µM ATP, which is maximal 
for all mutants studied.  All mutants had maximal currents of at least -3 µA (Table 
1), indicating that several million functional receptors were successfully delivered 
to the cell surface. 
Zinc potentiation was assayed (Fig. 2.3A) and quantified as described in 
Methods.  Wild type P2X2 exhibited mean zinc potentiation of about 7 while the 
zinc insensitive mutations previously studied (H120A and H213A) gave 
potentiation near 0.  All 34 mutants tested in this study gave detectable zinc 
potentiation (Fig. 2.3B).  None of the mutants showed a significant increase in 
zinc potentiation.  Five mutants (D82A, E85A, E91A, D136A, and D209A), all with 
an average zinc potentiation below 3, potentiated significantly less (p<0.01) than 
wild type P2X2.  Two other mutants (E115A and D281A) had error bars that 
extended below 3 and just missed passing our test of significance (with p<0.015 
but not <0.01).  We focused the rest of our studies of zinc potentiation on these 
seven mutants. 
In wild type P2X2, the potentiation to zinc declines as zinc concentration 
rises above 100 µM.  This is due to the action of a low affinity inhibitory site with 
an estimated IC50 of about 120 µM (Clyne et al. 2002a).  As a screen for whether 
any of these mutations might have altered the inhibitory zinc binding site, we 
compared the amplitude of responses to the EC10 concentration of ATP alone, the 
EC10 concentration of ATP plus 20 µM zinc, the EC10 concentration of ATP plus 
49 
 
1,000 µM zinc, and 1,000 µM ATP (a saturating concentration) alone (Fig. 2.4A).  
The quantitative index of zinc inhibition (Fig. 2.4B) was calculated as defined in 
Methods.  For wild type P2X2, the current declined about 5-fold as zinc was 
increased from 20 µM to 1,000 µM, such that the amplitude of responses to low 
ATP alone and low ATP plus 1,000 µM zinc were similar.  Of the 34 alanine 
mutants assayed, 25 exhibited no significant difference from the ~75% inhibition 
by 1,000 µM zinc measured in wild type P2X2.  Eight mutants, (E85A, E91A, 
E115A, D127A, D136A, E167A, D172A and D261) showed significantly enhanced 
zinc inhibition (Fig 2.4B; p<0.01), and one mutant (E84A) showed significantly 
decreased zinc inhibition.  An increase in zinc inhibition is opposite to the result 
expected if these residues were part of the inhibitory zinc binding site.  It should 
be noted that when the combination of low ATP and high zinc was applied or 
removed, currents of wild type P2X2 receptors showed transients at both the onset 
and the offset (see Fig 2.4A).  These transients are a manifestation of the slower 
on-kinetics and faster off-kinetics of the low affinity zinc inhibition as compared to 
the higher affinity zinc potentiation process (Clyne et al. 2002a).  The on and off 
transients were much larger in the currents of the E84A mutant (Fig. 2.4A). 
The decrease in either potentiation to low zinc (20 µM) or inhibition to high 
zinc (1,000 µM) might reflect an impeded ability to bind zinc at the modulatory 
sites, a diminution of communication between the occupied zinc binding site and 
the gating machinery, enhanced opposing modulation, or a general defect in 
channel gating.  In the latter case, these candidate mutants might have been 
expected to also be deficient in potentiation to protons, an allosteric modulator 
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(Nakazawa et al. 1997b) that acts at a different site (Clyne et al. 2002a).  In wild 
type receptors, application of an ATP concentration that produced an EC10 
response at pH 7.5 produced a large increase in current when the pH was 
dropped to 6.5.  Each of the mutants that were highly deficient in zinc potentiation 
or inhibition had pH potentiation that was indistinguishable from wild type P2X2 
(wild type 6.3±1.1, D82A 6.2±0.7, E84A 8.4±1.3, D85A 7.0±0.8, E91A 6.1±0.5, 
E115A 6.2±0.8, D136A 5.4±1.0, D209A 6.9±0.7, D281A 7.2±1.5), so none of 
these mutations produced a general defect in channel gating. 
 
Cysteines support greater zinc potentiation than alanines at several candidate 
sites 
 
To test the role of amino acid residues identified in the alanine screen, we 
generated individual cysteine substitutions at the candidate positions and 
determined their effects on zinc potentiation and inhibition.  If a candidate residue 
participates in zinc binding, it would be expected that the response to zinc would 
be enhanced in the “C” version over the “A” version, because it is known that 
cysteine residues perform better than non-polar alanine residues as ligands for 
zinc (Maret 2005).  Responses to ATP were recorded from all the cysteine 
substituted candidates.  Cysteine substitution increased zinc potentiation over 
alanine substitution at positions 82, 136, and 209.  There was no significant 
difference between zinc potentiation for A and C mutants at positions 84, 85, 91 




To test whether any of the cysteine substituted zinc modulation candidates 
were accessible to the positively charged, thiol-reactive compound MTSET 
(Javitch et al. 1994), oocytes expressing the cysteine substituted candidates were 
assayed for zinc potentiation or inhibition before and after treatment with MTSET.  
For a positive control to verify that the MTSET had not been degraded, we used 
H213C, which had previously been shown to be accessible to MTSET.  For 
H213C, MTSET treatment produced a significant decrease in potentiation as 
expected.  Of the cysteine substituted potentiation candidates, the zinc 
potentiation before and after MTSET treatment was significantly different for only 
D136C (Fig. 2.5B, C).  The other cysteine substituted mutants showed 
potentiation ratios similar to levels observed before MTSET treatment (Fig. 2.5C).  
These results show that position 136 is accessible to MTSET, and therefore 
meets an essential criterion for participation in a site coordinating extracellular 
zinc. 
Because oocytes expressing the E115A mutant showed modest zinc 
potentiation, the failure to see any zinc potentiation in oocytes expressing E115C 
was unexpected.  One possible explanation for this result is a cysteine at this site 
is unable to engage in zinc binding because it has been trapped in an unnatural 
disulfide bond with one of the 10 endogenous cysteines of the extracellular 
domain of P2X2.  To test this possibility, we treated oocytes expressing E115C 
with the reducing agent dithiothreitol (DTT), and then retested for zinc 
potentiation.  It had previously been demonstrated that DTT has no effect on zinc 
potentiation in wild type oocytes, but that receptors that carry cysteines replacing 
52 
 
both of the histidines required for zinc potentiation (H120C/H213C) form disulfide 
bonds that make them zinc resistant until after DTT treatment (Nagaya et al. 
2005).  Treatment of oocytes expressing E115C with DTT (10 mM for 5 minutes) 
caused no significant increase in potentiation to 20 µM zinc (before -0.6 ± 0.1, 
after -0.4 ± 0.1; N=3), while DTT caused a robust and highly significant increase in 
the positive control oocytes expressing the H120C/H213C double mutant (before 
0.1 ± 0.1, after 2.4 ± 0.4; N=3; p<0.001).  As the failure of E115C to allow zinc 
potentiation did not appear to be caused by trapping the cysteine in a disulfide 
bond, we considered the possibility that the absence of a negative charge at 
position 115 forced the receptor into a new conformation that either indirectly 
eliminated the zinc binding site, or prevented bound zinc from modifying channel 
gating.  To test these possibilities, we treated oocytes expressing E115C with 
MTSES, a negatively charged cysteine reactive reagent (Fig. 2.6). In contrast to 
the slight zinc inhibition shown before treatment (which gave negative zinc 
potentiation of -0.4 ± 0.1), MTSES treated oocytes expressing E115C showed 
pronounced potentiation to 20 µM zinc (4.2 ± 0.5; N=6; p<0.0001).  The zinc 
potentiation after MTSES treatment was a consequence of both a significant 
decrease in the response to low ATP alone (to 18% ± 3% of its previous 
amplitude) and an increase in the response to ATP plus 20 µM zinc (to 166% ± 
28% of its previous amplitude) with relatively little change in the response to a 
high concentration (2 mM) of ATP (85% ± 3%; N=6 for each).  The effect on 
E115C was specific for a negatively charged reagent, as treatment with positively 
charged MTSET had no effect on zinc potentiation on oocytes expressing E115C 
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(potentiation before = -0.5 ± 0.1; potentiation after = -0.2 ± 0.3).  However, 
MTSET treatment did decrease the amplitude of currents in response to low ATP 
(to 19% ± 5%) and the currents in response to 2 mM ATP (to 85% ± 8%; N=5), 
which were very similar to the effects of MTSES treatment on these parameters.  
There was no significant effect of MTSES treatment on the zinc potentiation of 
oocytes expressing wild type P2X2. 
The currents from oocytes expressing the E84C mutant showed several 
unexpected features (Fig. 2.7A).  Like wild type and the E84A mutant (Fig. 2.5A), 
the response of E84C to an EC10 concentration of ATP plus 20 µM zinc resulted in 
substantial zinc potentiation.  However, a large component of this potentiation was 
only transient, while in wild type and E84A it was sustained.  Furthermore, the 
steady state responses to low ATP plus 20 µM zinc or 1,000 µM zinc were quite 
similar in E84C, while in wild type and E84A the currents were much smaller in 
high zinc.  MTSET treatment of individual oocytes expressing E84C resulted in 
little or no change in the responses to low ATP alone or to low ATP plus 20 µM 
zinc (Fig. 2.7A), but the steady state inhibition by 1,000 µM zinc was substantially 
enhanced (Fig. 2.7A, B).  MTSET treatment of oocytes expressing E84C also 
attenuated the current evoked by 1,000 µM ATP alone (from 9,900 nA ± 1,100 to 





The goal of this study was to test whether any of the negatively charged 
residues in the extracellular domain of P2X2 might directly contribute to zinc 
binding.  As an initial test of this idea, we made alanine mutations at all 34 
extracellular positions at which either a glutamate or an aspartate was present, 
characterized the concentration response relation to ATP of each mutant and then 
carried out assays for zinc potentiation and zinc inhibition. 
 
General effects of mutation of negatively charged residues of P2X2 
When the sequences of the seven rat P2X receptors are compared, 7 of 
the 34 positions we tested have negatively charged residues only in P2X2.  Of the 
remaining positions tested, 16 have a negatively charged residue in two to four 
subunits, 3 have a negatively charged residue in five or six subunits, and 8 have a 
negatively charged residue in all seven subunits (Table 1).  When alanine was 
substituted at each of the 23 negatively charged positions that are not highly 
conserved, there were only modest changes in the concentration response 
relations for ATP.  Similarly, although conservation between multiple members of 
a gene family often indicates that a residue plays an essential role, we found only 
modest changes in the concentration response relations for ATP when the 11 
most highly conserved residues were replaced with alanines.  This agrees with 
previous work on all of the homologous residues in human P2X1 (Ennion et al. 
2001) and many of the same residues in rat P2X2 (Jiang et al. 2000).  Similar to 
the previous work, the mutants with the most distinctive phenotypes in our study 
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were E85A and D315A (which are equivalent to D89A and D316A in human 
P2X1).  In oocytes, both the P2X1 D89A and the P2X2 E85A mutants produce a 
modest rightward shift in ATP potency.  A previous attempt to express P2X2 E85A 
and D261A in HEK293 cells resulted in no detectable current (Jiang et al. 2000).  
Perhaps the ability to express very high levels of protein in oocytes accounted for 
our ability to observe currents from these mutants.  In all three studies, the most 
left-shifted mutant of the 11 conserved extracellular acidic residues was produced 
by placing an alanine at the position equivalent to D315 of rat P2X2.  All changes 
at this position are not equivalent, as mutation to valine resulted in a 60-fold 
decrease in ATP potency (Nakazawa et al. 1998).  In summary, neither the 
conserved nor the unconserved negative residues of the extracellular domain 
could be demonstrated to play an essential direct role in allowing P2X2 receptors 
to respond to ATP.  This stands in stark contrast to the dramatic effect on the 
EC50 caused by mutating some of the conserved positive residues of P2X 
receptors (Ennion et al. 2000, Jiang et al. 2000). 
 
Are any negatively charged resides involved in binding zinc? 
If a residue is required for binding zinc to the potentiating site, our 
expectation was that when the residue was replaced with an alanine the 
enhancement of ATP-evoked currents by 20 µM zinc would be substantially 
attenuated.  Of the 34 positions tested in our alanine scan, seven (D82, E85, E91, 
E115, D136, D209, and D281) showed substantial attenuation of zinc potentiation, 
although all showed normal pH potentiation.  Similarly, if a residue was required 
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for binding to the inhibitory site, then the attenuation of ATP-evoked currents in 
the presence of 1,000 µM zinc would be significantly lessened.  Only one mutant, 
E84A, passed this preliminary test.  Each of these 8 candidate residues was 
subjected to a secondary screen which involved producing mutants that carried a 
cysteine at each site under study and then testing the effect of MTSET on zinc 
modulation.  The rationale for this approach was that if the candidate residue is 
part of the zinc binding site, modification with a bulky compound like MTSET 
should occlude the site, and weaken zinc binding. 
The candidate for participation in the inhibitory zinc binding site, E84, can 
be ruled out as a participant in zinc binding, because MTSET treatment of oocytes 
expressing E84C resulted in greater zinc inhibition.  If position 84 contributed 
directly to zinc binding at the inhibitory site, less zinc inhibition would be the 
expected result.  It was also noted that zinc inhibition was significantly enhanced 
when alanine was placed in 8 positions.  Because the zinc concentration 
response relations for potentiation and inhibition overlap (Clyne et al. 2002a), it 
was not a surprise that some mutations that depressed zinc potentiation (E85A, 
E91A, E115A, and D136A) showed enhanced inhibition, as no change to the 
inhibitory process would be needed to obtain this result.  It is unclear how 
mutations D127A, E167A, D172A and D261A enhanced inhibition while producing 
no significant reduction of potentiation.  It was not surprising that the E84A 
mutation, which had a decreased ability to produce inhibition to high zinc did not 
result in enhanced potentiation to 20 µM zinc, because very little inhibition is 
produced in wild type oocytes by 20 µM zinc (Clyne et al. 2002a). 
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Of the seven candidates for participation in the potentiating site, only 
D136C showed significant attenuation of zinc potentiation following MTSET 
treatment.  However, even when the MTSET effect had reached saturation (as 
determined by a failure to change when the duration of MTSET exposure was 
doubled), substantial zinc potentiation remained after MTSET treatment.  Like the 
modification of D136C we report here, MTSET modification of H120C and H213C, 
residues known to be in the zinc binding site, produces only attenuation and not 
elimination of zinc potentiation.  One potential explanation is that although P2X2 
receptors are homotrimers with three zinc binding sites producing potentiation, it 
may not be possible to simultaneously modify all three zinc binding sites with 
MTSET. If this is so, residual zinc potentiation would be expected after MTSET 
treatment, because it was previously demonstrated that even a single zinc binding 
site is sufficient to produce substantial potentiation (Nagaya et al. 2005). 
Of the other six candidates for involvement in zinc binding to the excitatory 
site, the cysteine mutant E115C did not potentiate to zinc.  Additional experiments 
demonstrated that it is unlikely that E115 is in the potentiating zinc binding site, as 
MTSES treatment restored the ability to respond to zinc, while attaching such a 
large molecule to a cysteine in the zinc binding site would have been expected to 
occlude zinc binding.  There are two possible explanations why the cysteine 
mutants of the other five candidates did not have altered responses to zinc 
following MTSET treatment.  A simple one is that MTSET bound to the cysteine, 
but had no effect because the candidate residue was not near the zinc binding 
site.  An alternative is that one or more of these residues are part of the excitatory 
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zinc binding site, but MTSET was not able to access the cysteine replacing the 
endogenous residue.  This second explanation seems unlikely because we know 
that MTSET can access cysteines replacing the two histidines (H120 or H213) 
that are known to be part of the zinc binding site (Nagaya et al. 2005).  If these six 
candidates are not direct participants in zinc binding, what else might have 
caused alanine mutations at these sites to attenuate zinc potentiation?  A 
plausible idea is that these negative charges are essential for the normal 
execution of the conformational changes that follow zinc binding, but not for 
opening the channel in response to ATP alone, or to potentiation by acidic pH, 
both of which are relatively normal in these mutants. 
To summarize these results, none of the extracellular acidic residues is 
required for P2X2 function and the evidence presented here best supports D136 
as the most likely of the 34 residues tested to directly bind zinc at the potentiation 
site, while none of the tested residues is likely to directly coordinate zinc at the 
inhibitory site.  If D136 proves to be part of the excitatory zinc binding site, then 
one additional residue likely remains to be discovered, as most zinc sites are 
tetrahedral, and two histidines had previously been identified as participating in 
zinc binding.  It is potentially of interest that the position equivalent to D136 is also 
negatively charged in P2X1, P2X4, and P2X7.  P2X4 is able to potentiate in 
response to zinc (Wildman et al. 1999a, Xiong et al. 1999), while P2X1 and P2X7 
are inhibited by zinc (Virginio et al. 1997, Wildman et al. 1999b).  None of these 
subunits contain histidines at positions equivalent to H120 or H213 of P2X2, so if 





would have to look elsewhere in the sequence of this subunit for the rest of the 
excitatory binding site.  Similarly, if E84 proves to be involved in binding zinc at 
the inhibitory site of P2X2, one would have to seek a different site to explain zinc 
inhibition of P2X1 and P2X7, as a negative residue is not found at the equivalent 
position in these subunits (nor in any subunit other than P2X2). 
Table 1.  Characteristics of rat P2X2 receptors and mutant receptors with an 
alanine substitution at one negatively charged extracellular residue.  Values 
reported are the mean and the SEM for each construct tested.  N indicates the 
number of oocytes tested to determine the concentration response relation.  Data 
from additional oocytes were sometimes included in estimates of the maximal 
current.  The seven mutants with significantly decreased zinc potentiation (five 
with p<0.01 plus two additional mutants that differed from wild type at p<0.015) 
are indicated with light gray shading, and the one mutant with significantly 
decreased zinc inhibition is indicated with dark gray shading.  Asterisks indicate 
EC50s or Hill coefficients that were significantly different from wild type P2X2 







 Hill Coefficient  Peak inward 
current at -50 
mV (µA)  
N Number of rat 
P2X receptors 
with a negative 
residue at this 
position 
wild 
type 15 ± 1.3   1.9 ± 0.05   12.8 ± 1.6 20  
D57A 43 ± 9.9 *   1.3 ± 0.21 *  12.0 ± 1.4 6 4 
E59A 10 ± 0.6   1.9 ± 0.08  9.8 ± 1.5 4 6 
E63A 20 ± 6.9   1.0 ± 0.08 *  3.1 ± 0.3 9 2 
E77A 22 ± 1.0   1.7 ± 0.03  6.3 ± 1.4 5 1 
D78A 33 ± 5.5 *   1.6 ± 0.12  6.1 ± 1.0 5 2 
D82A 55 ± 8.0 *    1.1 ± 0.07 *  9.6 ± 1.2 11 7 
E84A 3 ± 0.2 *   2.1 ± 0.09  16.7 ± 1.4 5 1 
E85A 66 ± 5.2 *    1.8 ± 0.09  7.3 ± 1.9 8 7 
E91A 48 ± 6.6 *    1.4 ± 0.03 *  7.3 ± 0.4 5 1 
E103A 7 ± 1.0 *   1.9 ± 0.09  12.5 ± 1.5 6 1 
E115A 42 ± 2.7 *   1.5 ± 0.04  8.0 ± 0.7 5 7 
D127A 12 ± 1.4   3.0 ± 0.55 *  25.5 ± 5.3 9 7 
D128A 35 ± 2.9    1.3 ± 0.06 *  18.1 ± 1.4 6 3 
D129A 20 ± 1.5   1.9 ± 0.07  23.0 ± 4.6 5 4 
D136A 17 ± 3.6   2.0 ± 0.10  9.3 ± 1.5 6 4 
D154A 9 ± 0.6   3.2 ± 0.64 *  16.3 ± 1.6 5 1 
E159A 9 ± 0.3 *   4.1 ± 0.52 *  16.1 ± 1.7 8 7 
E167A 7 ± 0.3 *   1.3 ± 0.16 *  16.0 ± 3.2 5 7 
D168A 20 ± 2.5   1.5 ± 0.11  24.8 ± 2.8 5 4 
D172A 11 ± 0.6   1.7 ± 0.04  17.1 ± 2.4 5 2 
D209A 43 ± 4.5 *   1.5 ± 0.05 *  9.1 ± 0.5 6 2 
D217A 10 ± 0.5   2.1 ± 0.09  18.6 ± 2.2 5 2 
D219A 10 ± 0.3   1.8 ± 0.06  15.1 ± 1.0 5 2 
D221A 5 ± 0.7 *   2.3 ± 0.10 *  16.4 ± 3.2 6 2 
E234A 15 ± 1.0   1.8 ± 0.13  15.3 ± 0.8 6 1 
E238A 12 ± 1.4   1.5 ± 0.04 *  20.8 ± 2.8 6 2 
E242A 2 ± 0.2 *   1.9 ± 0.05  18.5 ± 2.4 5 5 
D259A 19 ± 3.0   1.7 ± 0.17  11.0 ± 1.8 5 4 
D261A 9 ± 0.5 *   2.0 ± 0.09  7.7 ± 0.8 8 7 
E264A 8 ± 0.4 *   2.3 ± 0.20 *  17.9 ± 3.7 7 1 
E266A 7 ± 0.4 *   1.7 ± 0.09  18.2 ± 2.1 5 2 
D277A 22 ± 4.2   1.2 ± 0.10 *  11.6 ± 2.2 5 6 
D281A 4 ± 0.3 *   1.9 ± 0.04  12.7 ± 2.0 6 2 







Figure 2.1.  Residues of the extracellular domain of P2X2 tested in this 
study. 
 
P2X2 receptors function as homotrimers.  The full length of one of the 
subunits (black) is shown with pieces of the two neighboring subunits (gray) that 
contribute to the intersubunit coordination of zinc at the potentiating site.  All of 
the negative residues in the extracellular region are numbered in accord with the 
rat P2X2 sequence.  Within the extracellular domain aspartate residues are 
shown in cyan, and glutamate residues are shown in red.  D or E residues with 
black outlines are conserved in at least 6 of the 7 rat P2X receptors.  The two 
extracellular histidines (H120 and H213) known to coordinate zinc between 
subunits at the site for potentiation are shown in yellow.  The seven other 
extracellular histidines are not shown.  With the exception of the histidines that 
bind zinc and the 10 conserved extracellular cysteines that are believed to form 5 
disulfide bonds (dashed lines), the relative positions of residues is unknown, so 
residues quite far apart in this schematic diagram might be physically quite close. 
 
Figure 2.2.  Method for obtaining ATP concentration response relations. 
A and B.  Representative traces illustrating concentration response 
relationship of wild type P2X2 receptors and the mutant D315A (the most left-
shifted mutant studied).  The numbers in the boxes above each trace indicate the 
ATP concentration in µM and the length of the boxes indicates the duration of 
each application.  All traces were obtained from Xenopus oocytes voltage 
clamped at -50 mV.  C. Concentration response relationships of oocytes 
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expressing wild type P2X2 and D315A.  The error bars represent the standard 
error of the mean (SEM). 
 
Figure 2.3.  Potentiation of wild type and mutant P2X2 receptors by 20 µM 
zinc. 
 
A. Representative traces from wild type P2X2 and each mutant receptor 
that was deficient in zinc potentiation.  Each construct was first tested with an 
amount of ATP that produced approximately 10% of the maximal response (EC10 
ATP), then with EC10 ATP plus 20 µM zinc, and finally with 1,000 µM ATP.  All 
traces were scaled so that the response to 1,000 µM ATP was of equal height.  
The current in response to this concentration of ATP produced a maximal 
response for all constructs.  The dotted line across all the traces represents the 
predicted amplitude of the current if zinc potentiation was unchanged.  The 
dashed line intersecting each trace indicates the actual amount of zinc 
potentiation.  B. Potentiation in response to 20 µM zinc for all mutants studied.  
Zinc potentiation was calculated as defined in Methods.  The dashed line 
indicates a potentiation ratio of 3.0.  For each construct, data from 5-10 oocytes 
were averaged.  Error bars represent the SEM.  Black bars indicate mutants that 
showed significantly reduced zinc potentiation (p<0.01) compared to wild type 
P2X2. Two additional mutants, E115A and D281A differed from wild type at 




Figure 2.4.  Inhibition of wild type and mutant P2X2 receptors by 1,000 µM 
zinc. 
 
A. Examples of inhibition by high zinc in wild type P2X2 and in mutants 
that showed less inhibition (E84A) and enhanced inhibition (D172A).  Each trace 
is the response as the bathing solution was switched from external solution alone 
to the indicated solutions for the duration indicated by the bar.  Five minutes of 
recovery was allowed between adjacent traces.  Zinc inhibition was determined 
based on the amplitude of the current with EC10 ATP + 1000 µM zinc (dashed 
line) and the current with EC10 ATP + 20 µM zinc (solid line).  B. Inhibition in 
response to 1,000 µM zinc for all mutants studied.  Zinc inhibition was calculated 
as defined in Methods, with 100% representing complete inhibition, and 0% 
representing no inhibition.  The dashed line indicates 50% inhibition.  For each 
construct, data from 3-10 oocytes were averaged.  Error bars represent the SEM.  
The black bar indicates the one mutant that showed significantly reduced zinc 
inhibition (p<0.01) compared to wild type P2X2.  Asterisks indicate mutants that 
showed significantly increased zinc inhibition (p<0.01) compared to wild type 
P2X2. 
 
Figure 2.5.  Zinc potentiation in mutants with cysteines at candidate zinc 
binding site locations. 
 
A. Potentiation to 20 µM zinc when an alanine or a cysteine was 
substituted at each indicated position.  Each bar represents the average zinc 
potentiation (as defined in Methods) of 4-9 oocytes for each construct assayed.  
White bars represent alanine mutants, gray bars represent cysteine mutants, and 
65 
 
error bars represent SEM.  The dashed line represents the mean potentiation for 
wild type.  The data for the alanine mutants are the same as shown in Figure 3. 
Asterisks indicate when the A and C mutants at the same position were 
significantly different (p<0.01).  B. Representative traces for wild type, H213C, 
and D136C expressing oocytes before and after MTSET treatment.  Zinc 
potentiation was present in the untreated H213C mutant, but was greatly reduced 
following a 1 minute exposure to 1 mM MTSET.  The dashed lines illustrate the 
expected amplitude of the current if MTSET did not interfere with zinc responses.  
C. Results from the MTSET experiments done on potentiation candidates shown 
as the mean potentiation before MTSET treatment (gray bars) and the mean 
potentiation after treatment (white bars).  Only the potentiated responses of 
oocytes expressing D136C and the H213C positive controls were significantly 
(p<0.01) reduced by MTSET treatment (asterisks).  Error bars represent SEM for 
3-7 oocytes per construct. 
 
Figure 2.6.  Effect of 20 µM zinc on oocytes expressing E115C before and 
after treatment with disulfide reactive reagents. 
 
Following the initial test for responses to ATP and zinc, each oocyte was 
incubated for 2 minutes in 10 mM of the indicated reagent and then washed for 
one minute (arrow) before being retested. A. MTSES restored zinc potentiation.  




Figure 2.7.  MTSET sensitivity of zinc inhibition in oocytes expressing 
E84C. 
 
A. Representative traces for E84C before and after treatment with 1 mM 
MTSET.  Shown are responses to low ATP, low ATP with 20 µM zinc, low ATP 
with 1,000 µM zinc, and 1,000 µM ATP.  B. Histogram representing the average 
percent inhibition of responses of E84A (N = 4), and E84C before and after 
treatment with MTSET (N = 6).  Error bars represent the SEM.  The dashed line 
represents the average percent inhibition for wild type P2X2 (76% ± 3%, N=6) 
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Extracellular acidic residues as pH sensors at rP2X2 receptors 
 
Introduction: 
Arthritis, infarction, tumor growth, and other forms of injury can cause 
levels of extracellular protons to increase from the normal physiological 
concentration (which produce a pH of ~7.6) to that typically associated with 
tissue acidosis (pH 7.0–6.0) (Reeh & Steen 1996).  Local acidosis is primarily 
sensed as pain.  Hydrogen ions are able to excite sensory afferents such as 
bullfrog dorsal root ganglion (DRG) neurons via the activation and/or modulation 
of inward cation-selective currents, including the acid-sensing ion channels 
(ASICs), the transient receptor potential vanilloid receptor 1 (TRPV1), and P2X 
receptors (Gerevich et al. 2007). 
ATP is the endogenous ligand that activates P2X receptors.  ATP is stored 
in neurosecretory vesicles, often together with other neurotransmitters and is 
released from neural cells and synaptic terminals via regulated exocytosis.  ATP 
is also released from non-neuronal cells including astrocytes and astrocyte-like 
cell lines (Lazarowski 2006).  In addition to vesicular release mechanisms, 
connexin hemichannels have been shown to mediate regulated release of ATP.  
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For example, hemichannels contribute to ATP release on mechanical stimulation 
in bovine corneal endothelial cells (Gomes et al. 2005).  In vascular endothelium, 
vesicular exocytosis, volume-regulated anion channels, and connexin 
hemichannels have been reported as candidates for ATP release pathways (Oike 
et al. 2004).  Data from physiological and pharmacological experiments suggests 
that ATP is released from taste cells via specific channels, likely to be connexin 
or pannexin hemichannels.  Tastant-responsive taste cells release the 
neurotransmitter ATP via a non-exocytotic mechanism dependent upon the 
generation of an action potential (Romanov et al. 2007). 
In peripheral tissues, large quantities of ATP may leave the intracellular 
space in response to tissue trauma, tumors, inflammation, migraine, or visceral 
distension.  The resulting P2X receptor activation and the subsequent 
depolarization of the sensory cell membrane initiate action potentials that are 
perceived centrally as pain.  Although sensory neurons express all known P2X 
subunits, the homomeric P2X3 and the heteromeric P2X2/3 receptors occur in 
these cells at the highest density (Gerevich et al. 2007). 
Many receptors have allosteric binding sites that modulate the activity of 
the receptor, contributing an additional level of complexity in the cell signaling 
process (Hogg et al. 2005).  Protons are capable of modulating the activity of a 
number of receptors and ion channels expressed by primary afferent nociceptors, 
including vanilloid receptors (Caterina et al. 1997), acid-sensitive channels of the 
degenerin family (Waldmann & Lazdunski 1998), and ATP gated channels 
(Stoop et al. 1997).  Protons have been shown to modulate ion channels through 
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effects on affinity of ligand binding (Varnum et al. 1995, Gordon et al. 1996), 
efficacy of channel gating (Jordt & Jentsch 1997), ion permeation ratio (Root & 
MacKinnon 1994), or altering the rate of receptor desensitization (Gerevich et al. 
2007). 
P2X2 receptors can be modulated by protons (Wildman et al. 1997), zinc 
(Cloues et al. 1993), copper (Xiong et al. 1999), neuroamines (Nakazawa & 
Ohno 1997), and some types of ion channels (Khakh et al. 2000, Wildman et al. 
2005).  The molecular basis of the sites of regulation by protons has been 
investigated in a number of mutagenesis studies on P2X receptor subtypes.  
P2X1, P2X2, P2X3, P2X4, and P2X7 have each been shown to have sensitivity to 
pH, with a non-conserved extracellular histidine residue serving as a proton 
sensor.  Acidification inhibits P2X1, P2X3, P2X4 and P2X7 receptor currents by 
increasing the EC50 value for ATP without a concomitant change in the maximum 
ATP effect.  The response of P2X2 receptors to protons is biphasic: acidic pH 
supports potentiation, while alkaline pH inhibits current (King et al. 1997).  
Protons potentiate both recombinant and native P2X2 receptor currents by 
reducing the EC50 value without altering the maximum effect of ATP (Acuna-
Castillo et al. 2007, Gerevich et al. 2007).  Prior studies have shown that histidine 
319 of P2X2 is necessary for wild type-like potentiation by low pH and that none 
of the other extracellular histidine (Clyne et al. 2002a) residues contributed to pH 
potentiation.  It remains unclear if other extracellular residues contribute to P2X2 
potentiation by protons.  The acidic residues glutamate and aspartate are 
electrostatically suitable to coordinate protons directly, but are titrated poorly at 
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physiological pH because of their low pKa’s of ~4.39  and ~4.04, respectively 
(Tollinger et al. 2002).  However, pKa-elevating carboxyl-carboxylate pairs can 
coordinate protons at more physiologically relevant pH (Morrill & MacKinnon 
1999). 
Glutamate residues have been shown to be important for acid sensing for 
the capsaicin receptor VR1.  VR1 is homologous to members of the transient 
receptor potential family of ion channels first identified in the Drosophila 
phototransduction pathway (Caterina et al. 1997, Montell & Rubin 1989).  Cells 
expressing wild-type VR1 receptors show especially dynamic modulation of heat-
evoked currents between pH 8 and 6, a sensitivity range that matches the extent 
of local acidosis attained during most forms of tissue injury (Reeh & Steen 1996).  
Extracellular protons are believed to modulate the capsaicin receptor primarily by 
increasing the probability of channel opening (Tominaga et al. 1998).  VR1 
mutants bearing other amino acids at the E600 site, E600D or E600H, do not 
exhibit the same robust and dynamic increase in heat-evoked currents over this 
pH range, highlighting the physiological significance of having glutamate at this 
position.  For E600Q or other mutants having non-titratable amino acids at this 
position, the magnitude of heat-evoked currents was largely independent of 
extracellular pH (Jordt et al. 2000).  These investigators speculated that E600 
formed a pair with an unidentified residue.  Another example where carboxyl-
carboxylate pairs serve as proton binding sites of ion channels are four glutamate 
residues that probably lie within the channel pore of cyclic nucleotide-gated 
(CNG) channels.  These CNG glutamate residues are thought to mediate the 
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proton-dependent transitions between different conductance states with a pKa 
~7.6 (Root & MacKinnon 1994, Wildman et al. 2005).  Similar pairings of pore 
glutamates confer proton-dependent block in L-type calcium channels with an 
even higher pKa of ~8.5, nearly four pH units greater than the pKa of an 
individual glutamate residue (Chen et al. 1996, Chen & Tsien 1997). 
The mechanism of proton sensing involving carboxyl-carboxylate pairs of 
acidic residues is best understood for Acid-sensing Ion Channels (ASICs).  
ASICs are a distinct family of extracellular proton-gated cation channels with 
some similarity in topology (Jasti et al. 2007) and distribution of expression 
(Masin et al. 2006) to P2XRs.  ASIC2b, a splice variant of ASIC2a, is acid-
insensitive.  Five extracellular sites occupied by protonatable residues in ASIC2a 
but not in ASIC2b may be involved in activation of ASIC2a by protons (Smith et 
al. 2007).  Mutation of ASIC2a Histidine 72 to an alanine abolishes the pH 
sensitivity of ASIC2a, however it is not the unique determinant of its pH 
sensitivity (Baron et al. 2001). 
Evidence from a report describing a low-pH crystal structure of chicken 
ASIC1 at 1.9 Å resolution demonstrated that acidic residues of the extracellular 
domain formed at least one proton-bearing carboxyl-carboxylate pair.  Asp 238–
Asp 350 and Glu 239–Asp 346 of chicken ASIC1 define two pairs of unusually 
close (2.8 Å) carboxyl-carboxylate interactions between the side chains of 
aspartate or glutamate residues.  Electrophysiological studies confirmed that the 
candidate aspartate residues are part of proton-sensing carboxyl-carboxylate 
pairs.  Neutralization of Asp 346 and Asp 350 had profound effects on either pH50 
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or apparent Hill coefficient, or both.  These results confirmed identification of two 
key residues involved in proton sensing, yet they also suggest that the pH sensor 
is distributed over multiple residues (Jasti et al. 2007). 
Because of this extensive body of work on other channel classes, we 
sought to test the hypothesis that negatively charged residues of the P2X2 




All methods were as detailed in Chapter 2 with the following additions: 
Solutions—For assaying pH potentiation, the pH of ATP solutions was adjusted 
to either 7.5 or 6.5 prior to recording.  All ATP recording solutions were used 
within 48 hours. 
 
Selection of ATP Concentrations and Quantification of pH Potentiation — 
ATP-evoked steady-state responses were measured with two-electrode 
voltage clamp recording 48 hours after injection of Xenopus oocytes with 50 nl 
RNA (100 ng/ µl) encoding P2X2 or mutants bearing single alanine substitutions 
at extracellular aspartate and glutamate residues.  To compare the magnitude of 
pH potentiation between groups of oocytes, it is essential that all of the oocytes 
be studied at similar points on the ATP concentration-response relation, because 
as the concentration of ATP increases, potentiation decreases so that there is no 
pH potentiation when a saturating concentration of ATP is present (Wildman et al. 
80 
 
1998).  Furthermore, the EC50 for ATP of different oocytes expressing the same 
construct can vary significantly (Clyne et al. 2003).  We dealt with these 
complications by testing each oocyte first with a low concentration of ATP at pH 
7.5, which we expected would be close to the EC10 based on the average 
concentration-response relation for each construct, and then with 1,000 μM ATP 
at pH 7.5, which was a maximal concentration for all constructs used in this 
study.  We set a criterion of responses to low ATP at pH 7.5 between 8-12% of 
the maximal response evoked by 1000 µM ATP (pH 7.5), which was a refinement 
from our previous screen for zinc potentiation and inhibition phenotypes.  We 
used a protocol that consisted of the following sequential applications without 
intervening washes: low ATP (pH 7.5), low ATP (pH 6.5), and 1000 µM ATP (pH 
7.5). 
 
Data Analysis—Data were analyzed using Clampfit and Microsoft Excel.  The F 
test was used to determine if the variance of the data was equal or unequal 
(p<0.01), and the significance of differences between groups was then tested 
using the two-tailed, unpaired t test function of Excel, with significance taken to 




To test whether mutation of negatively charged extracellular residues 
altered the responses of rat P2X2 receptors to a shift from the normal pH to a 
more acidic level, we used a three pulse protocol (Fig. 3.1A).  We first applied a 
concentration of ATP at pH 7.5 that produced approximately 10% of the maximal 
response to ATP, then switched to the same concentration of ATP at pH 6.5, and 
finally switched to 1,000 µM ATP at pH 7.5, a concentration that produced 
maximal responses to ATP at both pH 7.5 and 6.5.  Because potentiation is an 
allosteric effect, the fold potentiation diminishes as the ATP concentration rises.  
Therefore, data analysis was restricted to those cells for which the initial 
response was no less than 5% and no more than 15% of the final response to 
high ATP, and that the average for the population of cells was between 8 and 
12% of maximum (Fig. 3.1B).  We therefore refer to the first test pulse as low 
ATP. 
When care was taken to study cells close to the EC10, wild type P2X2 
receptors had approximately an 8 fold increase in current on being shifted from 
pH 7.5 to 6.5.  To quantify pH potentiation (Fig. 3.1C), we calculated a pH 
potentiation index (PPI): 
PPI = [current in low ATP (pH 6.5)/ current in low ATP (pH 7.5)]-1. 
With this index, an absence of potentiation produces a ratio of 0 and the 
maximum possible potentiation from an EC10 concentration of ATP is 9.0.  Thus, 
a PPI of 7 corresponds to ATP activation to 80% of maximal. 
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For wild type rP2X2, a concentration of ATP eliciting ~10% of the maximal 
response at pH 7.5 exhibited a PPI of 6.77 ± 0.69 when the pH of the external 
solution was lowered to 6.5.  For 33 of the 34 mutants tested, pH potentiation 
was not significantly different from wild type (Fig. 3.1C).  However, the mutant 
E63A showed significantly reduced potentiation (2.28 ± 0.25) compared with wild 
type rP2X2 (p < 0.0014, 2 tail t test; Fig. 3.1A, C). 
 
Discussion: 
Titration of free glutamate residues by protons usually occurs with a pKa 
~4.45 (Marti 2005).  However, carboxyl-carboxylate pairs can raise the pKa 
values above that of the respective single acidic residues of the binding site and 
into the normal physiological range (Morrill & MacKinnon 1999).  In the present 
study, we tested whether any of the 34 extracellular acidic residues were 
necessary for wild type-like pH potentiation of the rP2X2 receptor.  These alanine 
substituted mutants were previously characterized for channel function in a 
companion study that focused on the role of the extracellular aspartate and 
glutamate residues in modulation of the channel by divalent zinc (Friday & Hume 
2008).  None of these mutations produced non-functional channels or 
significantly affected ATP potency or channel gating, but 7 candidates were 
identified that exhibited deficient zinc potentiation.  All 7 of these zinc modulation 
candidates showed normal potentiation to acidic pH.  In the current work we 
found 26 additional sites at which substituting an alanine for a glutamate or 
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aspartate also did not significantly alter pH potentiation, and found a single site, 
E63A, that is substantially deficient in pH potentiation. 
As none of the extracellular histidines of rP2X2 are required for pH 
potentiation (Clyne et al, 2002a) (although potentiation is greatly attenuated in 
H319A), it was therefore tempting to speculate that the local microenvironment 
elevates the pKa of E63 so that it can be titrated at pH 6.5.  However, our results 
do not support the interpretation that the defect in pH potentiation observed for 
E63A was from disruption of a carboxyl-carboxylate pair mechanism for sensing 
protons. The prediction if this were the case was that negatively charged 
residues important for pH potentiation should be revealed not singly but in pairs, 
with mutations of either negatively charged residue of a proton-sensing carboxyl-
carboxylate pair producing similar changes in pH potentiation.   As none of the 
other 33 alanine substituted negatively charged extracellular positions exhibited 
potentiation defects at pH 6.5, the pH potentiation defect observed for E63A 
seems unlikely to represent disruption of a carboxyl-carboxylate pair.  To resolve 
this definitively, one could test double mutants of E63A and the remaining 33 
extracellular alanine-substituted acidic residues for exacerbation of the pH 
potentiation defect, or altogether abolition of potentiation by protons.  It also 
might be of interest to pair E63A with H319A, the only other residue known to 
show a deficit in pH potentiation. 
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 Figure Legend: 
Figure 3.1:  Effects of changes in the extracellular pH on currents through 
rat P2X2 receptors expressed in Xenopus oocytes. 
 
A. Representative traces of pH potentiation assays performed on Xenopus 
oocytes expressing saturating amounts of RNA encoding rP2X2 and 
E63A.  Horizontal bars represent the duration of application of low ATP 
(EC8-12, pH 7.5), low ATP (EC8-12, pH 6.5), and 1000 µM ATP (pH 7.5).  
The dotted line represents the maximal pH potentiation evoked by low 
ATP (pH 6.5) for oocytes expressing the E63A mutation.  The dashed line 
represents the magnitude of proton-potentiated current expected if pH 
potentiation was unaffected by the alanine substitutions.  The traces were 
re-scaled so that the maximal responses to 1000 µM ATP were similar.  
The time scale applies to each trace. 
B. Histogram demonstrating that all mutants were tested at close to the EC10 
for ATP at pH 7.5.  Error bars represent standard error of the mean (N= 3–
19). 
C. Histogram summarizing the results of experiments as in A for rP2X2 (white 
bar) and 34 mutants in which a single negatively charged amino acid was 
mutated to alanine.  Data are presented as the pH potentiation index (PPI) 
described in Results.  Only the E63A mutation exhibited a significantly 
reduced pH potentiation ratio (p<0.0014).  Error bars represent standard 
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In this thesis I set out to test whether any of the extracellular glutamates or 
aspartates of P2X2 might play an essential role in three processes, high affinity 
zinc binding that leads to potentiation of ATP responses, low affinity zinc binding 
that leads to inhibition of ATP responses and proton binding that leads to 
potentiation of ATP responses.  The focus was on these negatively charged 
residues because the phenotypes of mutations previously made to other potential 
candidates for involvement in these modulations (histidines and cysteines) 
seemed insufficient to fully account for these phenomena.  I identified a single 
residue (D136) that is a very strong candidate for involvement in the zinc 
potentiating site, a single residue that remains a candidate for involvement in a 
pH potentiating site (E63A) and no good candidates for involvement in the zinc 
inhibitory site, although I did find one mutation (E84A) that can significantly 
attenuate zinc inhibition.  I begin this section with consideration of the next steps 
that should be taken to understand each of these three binding sites, and end 
with a general consideration of the potential uses that might follow from 
understanding any of these allosteric sites in detail.
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Potential future experiments to explore the zinc potentiation site 
To gain further understanding of the mechanism by which D136A leads to 
attenuation of zinc potentiation, it would be of great interest to know if this 
residue is in close physical proximity to the known zinc coordinating residues 
H120 and H213.  To test whether this candidate acidic residue is in close enough 
proximity to directly participate in zinc binding with H120 and H213, we have 
initiated two parallel approaches. 
Electrophysiologically, when a double mutant of H120C/H213C H213C is 
expressed in Xenopus oocytes, there is a significant rightward shift in the ATP 
dose response relationship, and zinc potentiation is absent.  Treatment with the 
reducing agent DTT, shifts the ATP potency back toward that of wild type 
controls, and partially restores zinc potentiation. Furthermore, for some 
concentrations of ATP there is a very large increase in zinc potentiation after 
DTT treatment. 
Results from electrophysiology experiments performed so far have shown 
that the ATP dose response relationships for oocytes expressing the single 
mutants H120C, H213C, and D136C are similar to wild type, and responses to 
100 µM ATP before and after DTT are no different.  When the D136/H120C 
double mutant was tested, the ATP potency was shifted slightly to the left and the 
response to 100 µM ATP was unchanged by DTT treatment.  However, the 
D136C/H213C double mutant was right shifted similar to the H120C/H213C 
double mutant.  After DTT treatment, the responses evoked by 100 µM ATP 
significantly increased for the control H120C/H213C and the test D136C/H213C 
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combinations.  While these changes in receptor function are suggestive of an 
intersubunit disulfide occurring at the zinc binding site, an alternate possibility is 
that flexibility between subunits in this region of the ectodomain is sufficient to 
allow ectopic disulfides to form non-specifically with residues not at the binding 
site.  To test this possibility, electrophysiological recordings will be performed on 
the remaining 6 candidates as double mutants with either H120C or H213C. 
With respect to zinc potentiation, the control H120C/H213C showed a 
significant increase in zinc potentiation ratio after DTT treatment.  However, the 
results are not as clear for the test combinations D136C/H120C and 
D136C/H213C because it has been difficult to identify the concentration of ATP 
to evoke 10% of the maximal response, so most of the data generated so far are 
not within our established criteria for low ATP.  However, it is clear that the zinc 
potentiation ratios of the control H120C/H213C and D136C/H120C, 
D136C/H213C test combinations are lower than those of wild type and singly 
expressed H120C, H213C, and D136C mutations.  Larger sample sizes are 
needed to draw conclusions about whether the lower zinc potentiation can be 
restored by DTT treatment. 
Biochemically, under non-reducing SDS/PAGE conditions, P2X2 proteins 
from oocytes coexpressing the H120C and H213C constructs migrate as a mix of 
monomers and dimers and oocytes expressing the H120C/H213C double mutant 
migrate as trimers.  Under reducing conditions, both coexpressed proteins and 
proteins from double mutants migrate as monomers, consistent with formation of 
reductant-sensitive ectopic disulfides.  A prediction is that when D136C is in a 
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double mutant with either H120C or H213C, the channel function phenotypes 
resulting from either combination would not be equivalent, because one or the 
other should be an intersubunit ectopic disulfide, which might constrain global 
channel flexibility more than an intrasubunit ectopic disulfide.  The strategy for 
the biochemical approach has been to make double mutant constructs encoding 
H120C or H213C with the cysteine version of each of the seven identified zinc 
potentiation candidates, D82C, E85C, E91C, E115C, D136C, D209C, and 
D281C.  Protein extracted from HEK293 cells or Xenopus oocytes expressing 
these combinations will be resolved by denaturing SDS/PAGE under reducing 
and non-reducing conditions.  These studies are not yet complete, as only 
several of the possible combinations have been tested so far.  Efforts are 
currently underway to optimize western blotting protocols to reduce detection of 
spurious high molecular weight bands that confound interpretation. 
Regardless of whether D136 is proved to be part of the zinc binding site, 
we began with the assumption that the site would be tetrahedral, which if correct 
would imply that one residue remains to be identified (or two if D136 is 
subsequently ruled out). 
To look for the remaining zinc binding residues that mediate potentiation 
or inhibition at P2X2 receptors, one could move further down the list of likely 
candidates.  While histidine, cysteine, aspartate, and glutamate are the most 
common residues known to bind zinc, there are other candidates.  Lysine, a 
positively charged residue, has been shown by site-directed mutagenesis to be 
involved in high-affinity Zn2+ modulation of NMDA channels (Fayyazuddin et al. 
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2000) and ASIC1a (Chu et al. 2004).  Also, two polar, uncharged threonine 
residues of the GlyRα1 subunit, T112 and T133, have been shown by site-
directed mutagenesis to be important determinants of Zn2+-mediated inhibition of 
the glycine receptor (Laube et al. 2000, Miller et al. 2005).  Therefore, it might be 
reasonable to investigate the extracellular lysine and threonine residues for 
involvement in zinc modulation of P2X2 receptors. 
 
Potential future experiments to explore mechanism(s) of pH potentiation 
With respect to the mechanism by which E63 contributes to pH 
potentiation, there are several hypotheses that might explain these results that 
were discussed in detail in Chapter 3.  Briefly, the steric properties of glutamate 
63 may be a critical determinant of structural aspects of the proton binding site, in 
which case a glutamine substitution would be predicted to have a less dramatic 
effect on pH potentiation than an aspartate substitution.  Alternatively, the 
electrostatic properties of E63 may be the critical chemical feature enabling wild 
type-like pH potentiation, in which case an aspartate substitution would be 
predicted to be less dramatic than the effects of a glutamine substitution on pH 
potentiation. 
 
Mechanism of zinc inhibition 
The same classes of residues that were candidates for participation in the 
zinc potentiating binding site were candidates for participation in the inhibitory 
site.  The question of whether inhibition of current in response to high 
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concentrations of zinc (>100 µM) in the alanine substituted conserved 
extracellular cysteines was previously addressed by our lab.  It was noted that 
zinc inhibition was operative for each of the 10 mutants, although the magnitude 
of the inhibition was not quantitatively characterized.  As there is good evidence 
that all of these residues are in disulfide bonds, they do not seem to be promising 
candidates, although if the suggestion that one pair is not disulfide bonded 
(Coddou et al. 2007) were to be verified for P2X2, these residues should be 
tested.  Similarly, in the study of Clyne et al (2002a) the nine extracellular 
histidines of P2X2 were tested with a careful quantitative assay for participation in 
the potentiating zinc binding site, but it was simply noted that inhibition was 
present in all 9 alanine mutants without quantitation.  Therefore I believe that the 
role of the histidines in zinc inhibition should be looked at more carefully. 
To definitively assess whether the histidine residues are necessary for 
zinc inhibition, two approaches might be taken.  The first approach would be to 
rescreen the 9 alanine substituted histidine mutants with a more quantitative 
protocol like the one used here in the zinc inhibition screen of the aspartate and 
glutamate mutants.  The better, but more time consuming approach would be to 
make double mutants of each of the remaining seven histidines with H120A or 
H213A.  Because these mutants do not potentiate to zinc, but are inhibited by 
high concentrations of zinc, mutants that fail to exhibit inhibition would likely be 
more easily identified in this background. 
If a rescreen of the histidines (and possibility some cysteines) does not 
reveal the members of the zinc inhibitory site, the same approaches I mentioned 
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for the excitatory site would be relevant, although I would consider this to be of 
lower priority because the affinity of this site in rats is so low.  However, it should 
be noted that recent studies by Rachel Tittle in our lab have demonstrated that 
human P2X2 has no zinc potentiation and a much higher affinity inhibitory zinc 
binding site, so a higher priority than continuing to study the rat receptor should 
be to understand the nature of zinc inhibition on the human receptor. 
 
Additional modulatory actions on P2X2 that could be studied 
The focus of the work presented here has been to identify amino acids 
that play a role in the allosteric modulation of P2X2 by zinc and pH.  There are at 
least two other modulatory systems acting on P2X2, and there might be more.  
Previous work from our lab (Zhou & Hume 1998) demonstrated that P2X2 
receptors exhibit inward rectification and voltage-dependence of gating, which 
can affect receptor function.  Like the allosteric modulators zinc and pH, the 
effect of negative membrane potential is to decrease the concentrtation of ATp 
needed to achieve and EC50 response, with little change in the Hill coefficient or 
response to a maximal concentration of ATP. Work of others has shown that 
copper can potentiate P2X2 responses by acting at a site that probably has some 
residues in common with the high affinity zinc site, but is not identical to it (Lorca 
et al. 2005). 
I am nearing completion of a study testing whether any of the negative 
charges thought to be in the extracellular loop can alter the voltage dependence 
of P2X2 gating.  To date, I have completed tests on approximately one-fourth of 
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the 34 mutants, and I have found that none alter the amount of inward 
rectification in the current-voltage relation, which is an indicator of the amount of 
allosteric regulation by membrane potential.  Furthermore, for the following 
reason the likelihood that we will find anything is low.  Although charged amino 
acids are usually part of voltage sensing mechanisms for voltage-gated ion 
channels (Bezanilla 2008), in order to be part of a voltage sensor the charges 
have to be within the membrane voltage field, and in our current model of the 
P2X2 receptor, all of these residues are in the extracellular space.  However, 
because re-entrant loops into the membrane are a feature of some ion channels 
(Zhorov & Tikhonov 2004), and it has been recently proposed that P2X2 might 
have a reentrant loop in addition to the two transmembrane domains (Cao et al. 
2007) it seems worthwhile to complete this study.  It should be noted that human 
P2X2 shows voltage dependent modulation similar to rat P2X2 (Rachel Tittle, 
personal communication). 
 
The role of P2X2 modulatory mechanisms in normal physiology 
While my dissertation studies focused on only two allosteric ligands for 
P2X2 receptors, they nonetheless illustrate that the function of these channels 
can potentially be greatly influenced by molecules in the immediate milieu, 
adding a potential for complex regulation of channel activity.  An absolutely 
critical question for future studies is whether there are actually changes in the 
levels of zinc or pH (or copper) to make any of these binding sites physiologically 
meaningful.  Clearly the membrane potential does change enough to act upon 
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the voltage modulatory system.  In order to test the role of these modulatory 
systems in vivo, (probably through the use of knock in mice) two requirements 
must be met.  There must be mutants identified that significantly decrease, (or 
ideally eliminate) the modulatory process without affecting other receptor 
properties.  The H120A mutant seems ideal for testing the role of zinc 
potentiation, but the mutants that attenuate pH modulation (H319A and E63A), 
zinc inhibition (E84A), and voltage modulation (D315A) (Clyne et al. 2002a, 
Friday & Hume 2008, Zhou 1998), are not particularly potent or have other 
actions on receptor function and so it seems premature to consider building mice 
with these mutants.  However, there is a more serious problem, which is that the 
phenotype of mice with a complete knock out of P2X2 is quite mild (Cockayne et 
al. 2005) and so it is unclear how a mouse that was lacking one of these 
modulatory sites would be different from a wild type mouse. 
Because P2X2 knockout mice have been reported to show abnormalities 
in neuromuscular junction formation and ventilitory responses to hypoxia, knock 
in mice carrying the H120A mutation might allow one to determine whether 
normal zinc potentiation is necessary for P2X2 receptor function in those 
physiological roles. 
 
Potential uses that might arise from a better understanding of the allosteric 
binding sites of P2X receptors 
 
Positive and negative allosteric effectors are intriguing as potential 
therapeutic targets for different LGIC families, and may provide an additional and 
perhaps safer strategy for affecting the function of LGICs than agonists and 
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competitive or non-competitive inhibitors (Hogg et al. 2005).  Orthosteric agonists 
(those that act at the binding site for the primary ligand) can evoke sustained 
activation of the receptors, which can have a cytotoxic effect is the dosage is too 
high.  Alternatively, sustained exposure can cause receptor desensitization that 
may result in the opposite of the desired effects.  In contrast, the effects of an 
allosteric effector are limited by the nature of the receptor modulation, such that 
presence of higher concentrations of the modulator will saturate the effector sites 
but not result in effects beyond maximal modulation.  This ceiling effect 
sometimes offers a much larger safety margin in drug administration and 
compliance (Hogg et al. 2005). 
Specific examples of the utility of this approach are the use of 
benzodiazepenes such as valium as allosteric modulators of some types of 
GABA A receptors (Barbaccia et al. 1990), and the use of UCI-30002 [N-(1,2,3,4-
tetrahydro-1-naphthyl)-4-nitroaniline], a novel, negative allosteric modulator with 
selectivity for the major neuronal nAChR subtypes over muscle-type nAChRs 
(Yoshimura et al. 2007).  These therapeutics represents validation of the concept 
that allosteric modulators may have significant benefits as a strategy for treating 
some neurological disorders and smoking cessation. 
If allosteric modulation of P2X2 is indeed physiologically relevant, receptor 
specific positive allosteric therapeutics might be beneficial where there is an 
underlying condition of zinc deficiency or impaired zinc metabolism, while 
negative allosteric therapeutics might be indicated to attenuate activation of 
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